Enum: enum_CRDCH_Substance_substance_type
Autogenerated Enumeration for CRDC-H Substance substance_type
URI: crdch:enum_CRDCH_Substance_substance_type
Other properties
| Comments: | Name according to TCCM: "CRDC-H.Substance.substance_type" |
Permissible Values
| Text | Description | Meaning | Other Information |
|---|---|---|---|
| Autologous Anti-CD19 CAR-CD28 T-cells ET019002 | |||
| Enoblituzumab | |||
| PBN Derivative OKN-007 | |||
| Pan-mutation-selective EGFR Inhibitor CLN-081 | |||
| Cyclosporine | |||
| MEK 1/2 Inhibitor FCN-159 | |||
| Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020 | |||
| Phellodendron amurense Bark Extract | |||
| Lupartumab Amadotin | |||
| Goserelin | |||
| Anti-CD39 Monoclonal Antibody TTX-030 | |||
| Apomine | |||
| Sodium Dichloroacetate | |||
| Zinostatin | |||
| Tezacitabine Anhydrous | |||
| Carbendazim | |||
| Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011 | |||
| Anti-Denatured Collagen Monoclonal Antibody TRC093 | |||
| Endothelin Receptor Type A Antagonist YM598 | |||
| Abagovomab | |||
| Masoprocol | |||
| Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes | |||
| Autologous BCMA-targeted CAR T Cells LCAR-B4822M | |||
| Tubulin Polymerization Inhibitor CKD-516 | |||
| Anti-c-Met Monoclonal Antibody HLX55 | |||
| Anti-LAMP1 Antibody-drug Conjugate SAR428926 | |||
| Immunomodulatory Agent CC-11006 | |||
| Tepotinib | |||
| Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022 | |||
| Nortopixantrone | |||
| Troglitazone | |||
| Celecoxib | |||
| Ofatumumab | |||
| Ruthenium Ru-106 | |||
| Tubercidin | |||
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457 | |||
| Copper Cu 67 Tyr3-octreotate | |||
| MOv-gamma Chimeric Receptor Gene | |||
| Recombinant Human 6Ckine | |||
| Tafasitamab | |||
| PD-1 Directed Probody CX-188 | |||
| Immunoconjugate RO5479599 | |||
| siRNA-transfected Peripheral Blood Mononuclear Cells APN401 | |||
| Oleclumab | |||
| Anti-PD-1 Monoclonal Antibody AMG 404 | |||
| Lenvatinib | |||
| Toremifene | |||
| Anti-CD73 Monoclonal Antibody CPI-006 | |||
| Triazinate | |||
| Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119 | |||
| Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 | |||
| Colchicine-Site Binding Agent ABT-751 | |||
| Autologous Anti-BCMA CAR-transduced T-cells KITE-585 | |||
| Beauvericin | |||
| Porfiromycin | |||
| Nitric Oxide-Releasing Acetylsalicylic Acid Derivative | |||
| IDO/TDO Inhibitor LY-01013 | |||
| Fedratinib Hydrochloride | |||
| Sapitinib | |||
| Anti-ICOS Agonist Antibody GSK3359609 | |||
| CDK4/6 Inhibitor HS-10342 | |||
| Tiragolumab | |||
| Tamoxifen Citrate | |||
| Anti-PD-L1 Monoclonal Antibody MDX-1105 | |||
| Monomethyl Auristatin E | |||
| Anaxirone | |||
| Cisplatin-E Therapeutic Implant | |||
| Favezelimab | |||
| 2-Hydroxyestrone | |||
| PARP/Tankyrase Inhibitor 2X-121 | |||
| KSP Inhibitor AZD4877 | |||
| Sitimagene Ceradenovec | |||
| Staurosporine | |||
| Anti-CD70 Antibody-drug Conjugate SGN-CD70A | |||
| SR-BP1/HSI Inhibitor SR31747A | |||
| Puquitinib Mesylate | |||
| Epothilone KOS-1584 | |||
| Cantrixil | |||
| Olinvacimab | |||
| Telomerase-specific Type 5 Adenovirus OBP-301 | |||
| Uroacitides | |||
| Urelumab | |||
| Dacetuzumab | |||
| p53/HDM2 Interaction Inhibitor CGM097 | |||
| PEG-interleukin-2 | |||
| Saracatinib | |||
| Yttrium Y-90 Tacatuzumab Tetraxetan | |||
| Grapiprant | |||
| Tavokinogene Telseplasmid | |||
| Pol I Inhibitor CX5461 | |||
| Immunotoxin CMD-193 | |||
| pan FGFR Inhibitor PRN1371 | |||
| Enterococcus gallinarum Strain MRx0518 | |||
| Mitindomide | |||
| Ganitumab | |||
| Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine | |||
| Modotuximab | |||
| Trofosfamide | |||
| Tipiracil | |||
| Lorukafusp alfa | |||
| PSMA/CD3 Tri-specific T-cell Activating Construct HPN424 | |||
| GS/pan-Notch Inhibitor BMS-986115 | |||
| Cantuzumab Ravtansine | |||
| Navarixin | |||
| Anti-mesothelin Antibody-drug Conjugate BMS-986148 | |||
| Sunitinib Malate | |||
| Olutasidenib | |||
| Enasidenib | |||
| PEG-Proline-Interferon Alfa-2b | |||
| Anti-CD32B Monoclonal Antibody BI-1206 | |||
| Vedolizumab | |||
| Sodium Iodide I-131 | |||
| Pravastatin Sodium | |||
| CBP/beta-catenin Modulator E7386 | |||
| Monoclonal Antibody A1G4 Anti-Idiotype Vaccine | |||
| Itacitinib Adipate | |||
| Glesatinib | |||
| Vocimagene Amiretrorepvec | |||
| Upamostat | |||
| Anti-CD47 Monoclonal Antibody Hu5F9-G4 | |||
| EP4 Antagonist ONO-4578 | |||
| Anti-HER2 Monoclonal Antibody CT-P6 | |||
| Vinorelbine | |||
| Anti-CLEC12A/CD3 Bispecific Antibody MCLA117 | |||
| IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000 | |||
| Tritylcysteine | |||
| Octreotide Acetate | |||
| Anti-RANKL Monoclonal Antibody GB-223 | |||
| Akt Inhibitor SR13668 | |||
| IL-12-expressing HSV-1 NSC 733972 | |||
| Ivosidenib | |||
| STING Agonist TAK-676 | |||
| CYP17 Inhibitor CFG920 | |||
| Monoclonal Antibody NEO-201 | |||
| pan-PI3K Inhibitor CLR457 | |||
| Anti-EGFR Monoclonal Antibody SYN004 | |||
| Sonidegib | |||
| Atamestane | |||
| Adenoviral Cancer Vaccine PF-06936308 | |||
| Beta-lapachone Prodrug ARQ 761 | |||
| Recombinant Human TRAIL-Trimer Fusion Protein SCB-313 | |||
| Vesencumab | |||
| Gemcitabine Hydrochloride Emulsion | |||
| SDF-1 Receptor Antagonist PTX-9908 | |||
| Gusperimus Trihydrochloride | |||
| Valrubicin | |||
| Lenalidomide | |||
| Multi-AGC Kinase Inhibitor AT13148 | |||
| Prednisolone Acetate | |||
| CSF1R Inhibitor PLX73086 | |||
| Anti-BTLA Monoclonal Antibody TAB004 | |||
| Belantamab Mafodotin | |||
| Volociximab | |||
| Paclitaxel Trevatide | |||
| LAIR-2 Fusion Protein NC410 | |||
| Bevacizumab | |||
| Radgocitabine Hydrochloride | |||
| Anti-TIM-3 Antibody BMS-986258 | |||
| BH3 Mimetic ABT-737 | |||
| G Protein-coupled Estrogen Receptor Agonist LNS8801 | |||
| Anti-FGFR3 Antibody-drug Conjugate LY3076226 | |||
| Taxane Compound | |||
| Anti-CD30 Monoclonal Antibody XmAb2513 | |||
| Imgatuzumab | |||
| Mitobronitol | |||
| Uproleselan | |||
| IDH1(R132) Inhibitor IDH305 | |||
| Allogeneic Renal Cell Carcinoma Vaccine MGN1601 | |||
| HSP90alpha/beta Inhibitor TAS-116 | |||
| Clomesone | |||
| Squalamine Lactate | |||
| cEt KRAS Antisense Oligonucleotide AZD4785 | |||
| Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310 | |||
| Parvovirus H-1 | |||
| Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101 | |||
| Fimepinostat | |||
| Chlorambucil | |||
| Lapuleucel-T | |||
| Trifluridine | |||
| Anti-GD3 Antibody-drug Conjugate PF-06688992 | |||
| Src Kinase Inhibitor M475271 | |||
| Onatasertib | |||
| Iodine I 131 Monoclonal Antibody 81C6 | |||
| Nitroglycerin Transdermal Patch | |||
| Amuvatinib | |||
| Diarylsulfonylurea Compound ILX-295501 | |||
| Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10 | |||
| LMB-2 Immunotoxin | |||
| Doxifluridine | |||
| Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101 | |||
| Nanoparticle Albumin-Bound Docetaxel | |||
| Vorasidenib | |||
| Deuteporfin | |||
| Recombinant Interferon Alfa-2a | |||
| Anti-BCMA Antibody-drug Conjugate CC-99712 | |||
| Class 1/4 Histone Deacetylase Inhibitor OKI-179 | |||
| Natalizumab | |||
| VEGFR/FGFR Inhibitor ODM-203 | |||
| Foslinanib Disodium | |||
| Flanvotumab | |||
| Silibinin | |||
| Porcupine Inhibitor ETC-1922159 | |||
| PARP Inhibitor E7016 | |||
| N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea | |||
| Ilginatinib | |||
| Dengue Virus Adjuvant PV-001-DV | |||
| BET Inhibitor CPI-0610 | |||
| Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002 | |||
| Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 | |||
| Plinabulin | |||
| Olaratumab | |||
| Anti-CTGF Monoclonal Antibody FG-3019 | |||
| Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015 | |||
| Cintirorgon | |||
| Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370 | |||
| PARP Inhibitor CEP-9722 | |||
| SLCT Inhibitor GNS561 | |||
| Decitabine and Cedazuridine | |||
| Ceritinib | |||
| Aurora Kinase/VEGFR2 Inhibitor CYC116 | |||
| Anti-c-fms Monoclonal Antibody AMG 820 | |||
| Leuprolide | |||
| Spherical Nucleic Acid Nanoparticle NU-0129 | |||
| NLRP3 Agonist BMS-986299 | |||
| Oxcarbazepine | |||
| Bendamustine Hydrochloride | |||
| Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83 | |||
| BRAF Inhibitor ARQ 736 | |||
| Anti-SIRPa Monoclonal Antibody CC-95251 | |||
| Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343 | |||
| EGFR/VEGFR/RET Inhibitor HA121-28 | |||
| Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522 | |||
| EGFR T790M Antagonist BPI-15086 | |||
| Oncolytic Herpes Simplex Virus-1 ONCR-177 | |||
| Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC | |||
| Antibody-drug Conjugate SC-002 | |||
| Therapeutic Cancer Vaccine ATP128 | |||
| Chiauranib | |||
| Hsp90 Inhibitor BIIB028 | |||
| Mirvetuximab Soravtansine | |||
| Autologous Tumor Infiltrating Lymphocytes LN-145 | |||
| Anti-EGFR Monoclonal Antibody EMD 55900 | |||
| Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66 | |||
| Anti-CTLA4 Monoclonal Antibody BMS-986218 | |||
| Troriluzole | |||
| PDK1 Inhibitor AR-12 | |||
| Anti-A33 Monoclonal Antibody KRN330 | |||
| PI3K-gamma Inhibitor IPI-549 | |||
| Arcitumomab | |||
| Topixantrone | |||
| Ingenol Mebutate | |||
| Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2 | |||
| PRMT5 Inhibitor PRT811 | |||
| Anti-PD-L1 Monoclonal Antibody MSB2311 | |||
| ALK Inhibitor | |||
| Chemotherapy | |||
| Oncolytic Virus ASP9801 | |||
| Anti-ICOS Monoclonal Antibody KY1044 | |||
| Autologous Clonal Neoantigen T Cells ATL001 | |||
| Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100 | |||
| Toripalimab | |||
| 7-Cyanoquinocarcinol | |||
| Guadecitabine | |||
| Valemetostat | |||
| Sizofiran | |||
| Anti-FAP/Interleukin-2 Fusion Protein RO6874281 | |||
| PH20 Hyaluronidase-expressing Adenovirus VCN-01 | |||
| Iodine I 131 Monoclonal Antibody G-250 | |||
| Bispecific Antibody MDX-H210 | |||
| Acetylcysteine | |||
| Aceglatone | |||
| Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633 | |||
| Yttrium Y 90 Resin Microspheres | |||
| Anhydrous Enol-oxaloacetate | |||
| V930 Vaccine | |||
| Amuvatinib Hydrochloride | |||
| MEK Inhibitor PD0325901 | |||
| Anti-CD70 Antibody-Drug Conjugate MDX-1203 | |||
| Sialyl Tn Antigen | |||
| Cedazuridine/Azacitidine Combination Agent ASTX030 | |||
| Cyclophosphamide Anhydrous | |||
| Anti-HER2 Bi-specific Monoclonal Antibody ZW25 | |||
| CAIX Inhibitor SLC-0111 | |||
| Monoclonal Antibody 81C6 | |||
| Integrin Receptor Antagonist GLPG0187 | |||
| Temsirolimus | |||
| Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404 | |||
| FLT3/KIT Kinase Inhibitor AKN-028 | |||
| PIM Kinase Inhibitor TP-3654 | |||
| FLT3 Inhibitor FF-10101 Succinate | |||
| Anti-CTLA-4 Probody BMS-986288 | |||
| Rebastinib Tosylate | |||
| Rituximab Conjugate CON-4619 | |||
| Anti-CD73 Monoclonal Antibody TJ4309 | |||
| Polysialic Acid | |||
| Selective Estrogen Receptor Modulator CC-8490 | |||
| BMI1 Inhibitor PTC596 | |||
| S1P Receptor Agonist KRP203 | |||
| G-Quadruplex Stabilizer BMVC | |||
| Src/tubulin Inhibitor KX02 | |||
| ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471 | |||
| 2-Hydroxyoleic Acid | |||
| Brequinar | |||
| Theliatinib | |||
| XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 | |||
| iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596 | |||
| S-equol | |||
| Mcl-1 Inhibitor MIK665 | |||
| Futibatinib | |||
| Betulinic Acid | |||
| Radgocitabine | |||
| Tubulin Inhibitor ALB-109564 | |||
| FGFR4 Inhibitor BLU 9931 | |||
| Chlorozotocin | |||
| Inactivated Oncolytic Virus Particle GEN0101 | |||
| PIM Kinase Inhibitor SGI-1776 | |||
| Nedaplatin | |||
| Nogalamycin | |||
| Omipalisib | |||
| Idronoxil Suppository NOX66 | |||
| Anti-PD-1/CD47 Infusion Protein HX009 | |||
| Recombinant Interferon Beta | |||
| Anti-HER2 Bispecific Antibody-drug Conjugate ZW49 | |||
| Valspodar | |||
| Apoptosis Inducer GCS-100 | |||
| FGFR Inhibitor Debio 1347 | |||
| BCG Solution | |||
| Neoantigen-based Glioblastoma Vaccine | |||
| Pirarubicin Hydrochloride | |||
| Chk1 Inhibitor GDC-0425 | |||
| Polyethylene Glycol Recombinant Endostatin | |||
| Anti-CD19 Monoclonal Antibody MDX-1342 | |||
| Nanoscale Coordination Polymer Nanoparticles CPI-100 | |||
| Triptorelin Pamoate | |||
| Corticorelin Acetate | |||
| MEK 1/2 Inhibitor AS703988/MSC2015103B | |||
| Bcl-2 Inhibitor S65487 | |||
| JAK2 Inhibitor BMS-911543 | |||
| Bisthianostat | |||
| Naptumomab Estafenatox | |||
| Radium Ra 224-labeled Calcium Carbonate Microparticles | |||
| DR5-targeting Tetrameric Nanobody Agonist TAS266 | |||
| Ursolic Acid | |||
| Botanical Agent LEAC-102 | |||
| Glasdegib | |||
| Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94 | |||
| Geldanamycin | |||
| PSA/PSMA DNA Plasmid INO-5150 | |||
| Nanocell-encapsulated miR-16-based microRNA Mimic | |||
| Peptichemio | |||
| Tovetumab | |||
| hTERT Vaccine V934/V935 | |||
| Survivin mRNA Antagonist EZN-3042 | |||
| Apitolisib | |||
| Recombinant Interferon | |||
| Hsp90 Inhibitor BIIB021 | |||
| Aranose | |||
| Annamycin | |||
| Penicillamine | |||
| Abituzumab | |||
| Dexanabinol | |||
| Anti-c-Met Antibody-drug Conjugate TR1801 | |||
| PI3K Alpha/Beta Inhibitor BAY1082439 | |||
| Aurora B Serine/Threonine Kinase Inhibitor TAK-901 | |||
| Batabulin | |||
| Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 | |||
| dUTPase/DPD Inhibitor TAS-114 | |||
| BET Inhibitor GSK2820151 | |||
| Mitomycin B | |||
| Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B | |||
| OX40L-expressing Oncolytic Adenovirus DNX-2440 | |||
| Prolgolimab | |||
| Yttrium Y 90 Monoclonal Antibody B3 | |||
| Lutetium Lu-177 Rituximab | |||
| CDK9 Inhibitor AZD4573 | |||
| ALK Inhibitor TAE684 | |||
| Crizotinib | |||
| Batimastat | |||
| Ivuxolimab | |||
| Immediate-release Onapristone | |||
| Daclizumab | |||
| Vincristine Sulfate | |||
| Octreotide | |||
| Trilaciclib | |||
| Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564 | |||
| Clomiphene | |||
| Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022 | |||
| Liposomal Irinotecan | |||
| Tamibarotene | |||
| Balstilimab | |||
| Anti-TGF-beta RII Monoclonal Antibody IMC-TR1 | |||
| Pegylated Paclitaxel | |||
| Anti-CD137 Agonistic Monoclonal Antibody AGEN2373 | |||
| Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate | |||
| Anti-PD-1 Monoclonal Antibody LZM009 | |||
| Nilotinib Hydrochloride Anhydrous | |||
| Ropeginterferon Alfa-2B | |||
| Radium Ra 223 Dichloride | |||
| Naxitamab | |||
| Anti-CD20 Monoclonal Antibody B001 | |||
| ALK Inhibitor ASP3026 | |||
| Anti-IL-8 Monoclonal Antibody HuMax-IL8 | |||
| RAD51 Inhibitor CYT-0851 | |||
| Sulofenur | |||
| Yttrium Y 90 Tabituximab Barzuxetan | |||
| Hsp90 Antagonist KW-2478 | |||
| Spartalizumab | |||
| Arabinoxylan Compound MGN3 | |||
| Tasisulam | |||
| Dual-affinity B7-H3/CD3-targeted Protein MGD009 | |||
| Cinobufotalin | |||
| Recombinant Super-compound Interferon | |||
| Vaccine-Sensitized Draining Lymph Node Cells | |||
| Anti-HB-EGF Monoclonal Antibody KHK2866 | |||
| Tagraxofusp-erzs | |||
| Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230 | |||
| Anti-HER2 Immune Stimulator-antibody Conjugate NJH395 | |||
| Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 | |||
| Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A | |||
| Sonolisib | |||
| Alpha-tocopheryloxyacetic Acid | |||
| Relacorilant | |||
| Atiprimod Dihydrochloride | |||
| Yttrium Y 90 Monoclonal Antibody Hu3S193 | |||
| Lifastuzumab Vedotin | |||
| Personalized Neoantigen DNA Vaccine GNOS-PV01 | |||
| Palifosfamide Tromethamine | |||
| Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules | |||
| c-Met Inhibitor GST-HG161 | |||
| Anti-CDH6 Antibody-drug Conjugate HKT288 | |||
| Yiqi-yangyin-jiedu Herbal Decoction | |||
| AXL Inhibitor DS-1205c | |||
| EP4 Antagonist INV-1120 | |||
| Cenisertib | |||
| Cevostamab | |||
| Liposomal Daunorubicin Citrate | |||
| Wee1 Kinase Inhibitor Debio 0123 | |||
| Picoplatin | |||
| Iodine I 124 Monoclonal Antibody A33 | |||
| Camidanlumab Tesirine | |||
| Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003 | |||
| Tergenpumatucel-L | |||
| HIF-2alpha Inhibitor PT2977 | |||
| Anti-5T4 Antibody-Drug Conjugate PF-06263507 | |||
| Talotrexin Ammonium | |||
| Trastuzumab Duocarmazine | |||
| DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015 | |||
| Anti-CTLA-4 Monoclonal Antibody BCD-145 | |||
| Pexastimogene Devacirepvec | |||
| Bortezomib | |||
| HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN | |||
| Therapeutic Estradiol | |||
| TRK Inhibitor AZD6918 | |||
| Oregovomab | |||
| Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042 | |||
| Rilimogene Galvacirepvec/Rilimogene Glafolivec | |||
| Atiprimod | |||
| TLR7/8/9 Antagonist IMO-8400 | |||
| Cetuximab | |||
| Ispinesib Mesylate | |||
| Inalimarev | |||
| Fruquintinib | |||
| Sam68 Modulator CWP232291 | |||
| Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466 | |||
| iPSC-derived Natural Killer Cells FT500 | |||
| Teglarinad | |||
| FLT3 Tyrosine Kinase Inhibitor TTT-3002 | |||
| Telomerase Inhibitor FJ5002 | |||
| Racotumomab | |||
| MDM2 Antagonist ASTX295 | |||
| c-Met Inhibitor MSC2156119J | |||
| Androgen Receptor Antagonist TAS3681 | |||
| Cixutumumab | |||
| Azimexon | |||
| Aurora A Kinase Inhibitor LY3295668 | |||
| Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360 | |||
| Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514 | |||
| Lomustine | |||
| Anti-HER2-DM1 Antibody-drug Conjugate GQ1001 | |||
| PD-L1/PD-L2/VISTA Antagonist CA-170 | |||
| PI3K-delta Inhibitor PWT143 | |||
| LMP-2:419-427 Peptide Vaccine | |||
| Anti-OX40 Agonist Monoclonal Antibody ABBV-368 | |||
| Anti-DKK1 Monoclonal Antibody BHQ880 | |||
| Palladium Pd-103 | |||
| Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells | |||
| pan-PIM Kinase Inhibitor NVP-LGB-321 | |||
| Ibandronate Sodium | |||
| Amsilarotene | |||
| Wobe-Mugos E | |||
| Ixazomib Citrate | |||
| Anti-CD137 Agonistic Monoclonal Antibody ADG106 | |||
| Orelabrutinib | |||
| HDAC/EGFR/HER2 Inhibitor CUDC-101 | |||
| Pterostilbene | |||
| Padoporfin | |||
| Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s | |||
| HPPH | |||
| Flutamide | |||
| Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01 | |||
| Iobenguane I-131 | |||
| Venetoclax | |||
| Adenosine A2A Receptor Antagonist CS3005 | |||
| Interferon-gamma-expressing Adenovirus Vaccine ASN-002 | |||
| Oncolytic HSV-1 C134 | |||
| Interferon | |||
| Indoximod | |||
| Macrocycle-bridged STING Agonist E7766 | |||
| Flumatinib Mesylate | |||
| Monoclonal Antibody HeFi-1 | |||
| Nocodazole | |||
| Epcoritamab | |||
| SarCNU | |||
| Antibody-drug Conjugate ABBV-155 | |||
| FASN Inhibitor TVB-2640 | |||
| Anti-CLEVER-1 Monoclonal Antibody FP-1305 | |||
| Etoprine | |||
| Lapatinib Ditosylate | |||
| Aerosolized Liposomal Rubitecan | |||
| Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858 | |||
| Dihydroorotate Dehydrogenase Inhibitor AG-636 | |||
| ATR Kinase Inhibitor M6620 | |||
| Recombinant Interferon Alfa | |||
| Bemcentinib | |||
| Encelimab | |||
| Amatuximab | |||
| Paclitaxel Liposome | |||
| Plevitrexed | |||
| PD-L1 Inhibitor GS-4224 | |||
| Cergutuzumab Amunaleukin | |||
| Synthetic hTERT DNA Vaccine INO-1400 | |||
| CAR T-Cells AMG 119 | |||
| LRP5/6 Antagonist BI 905677 | |||
| Birinapant | |||
| Telaglenastat Hydrochloride | |||
| Cevipabulin Succinate | |||
| Platinum | |||
| Anti-CD137 Agonistic Monoclonal Antibody CTX-471 | |||
| Survivin-expressing CVD908ssb-TXSVN Vaccine | |||
| Yttrium Y 90-DOTA-di-HSG Peptide IMP-288 | |||
| Kanitinib | |||
| Molibresib Besylate | |||
| OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule | |||
| Deoxycytidine Analogue TAS-109 Hydrochloride | |||
| Nogapendekin Alfa | |||
| Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A | |||
| Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a | |||
| PI3K-beta Inhibitor SAR260301 | |||
| Anti-PD-1 Monoclonal Antibody HX008 | |||
| Pemlimogene Merolisbac | |||
| ERK Inhibitor GDC-0994 | |||
| Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B | |||
| Anti-TIGIT Monoclonal Antibody SGN-TGT | |||
| Tyroserleutide | |||
| BMS-275183 | |||
| HER2-targeting Antibody Fc Fragment FS102 | |||
| Opioid Growth Factor | |||
| Lutetium Lu 177 DOTA-N3-CTT1403 | |||
| p70S6K/Akt Inhibitor MSC2363318A | |||
| Thiarabine | |||
| Lucatumumab | |||
| DI-Leu16-IL2 Immunocytokine | |||
| Hsp90 Inhibitor XL888 | |||
| Allovectin-7 | |||
| Interferon Beta-1A | |||
| Pan-IDH Mutant Inhibitor AG-881 | |||
| Vitespen | |||
| Bleomycin Sulfate | |||
| Bizalimogene Ralaplasmid | |||
| Therapeutic Hydrocortisone | |||
| Antibody-drug Conjugate SC-004 | |||
| Camptothecin Sodium | |||
| SIRPa-IgG4-Fc Fusion Protein TTI-622 | |||
| Anti-TIGIT Monoclonal Antibody COM902 | |||
| Isatuximab | |||
| Anti-CD38-targeted IgG4-attenuated IFNa TAK-573 | |||
| BRAF/EGFR Inhibitor BGB-283 | |||
| Ranolazine | |||
| LSD1 Inhibitor RO7051790 | |||
| Mitoxantrone | |||
| ATR Kinase Inhibitor VX-803 | |||
| Iproplatin | |||
| Pegylated Recombinant Human Arginase I BCT-100 | |||
| Piperazinedione | |||
| Miptenalimab | |||
| Anti-CA19-9 Monoclonal Antibody 5B1 | |||
| Anti-TIM-3 Monoclonal Antibody MBG453 | |||
| Total Androgen Blockade | |||
| CD47 Antagonist ALX148 | |||
| c-Met Inhibitor AL2846 | |||
| Arginase Inhibitor INCB001158 | |||
| Daunorubicin | |||
| Daunorubicin Hydrochloride | |||
| Anastrozole | |||
| GSK-3 Inhibitor LY2090314 | |||
| Oxidopamine | |||
| IDO1/TDO2 Inhibitor DN1406131 | |||
| Rigosertib Sodium | |||
| P-p68 Inhibitor RX-5902 | |||
| LSD1 Inhibitor CC-90011 | |||
| Anti-Nucleolin Aptamer AS1411 | |||
| Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 | |||
| Conatumumab | |||
| Ipilimumab | |||
| CENP-E Inhibitor GSK-923295 | |||
| Indusatumab Vedotin | |||
| Trastuzumab Conjugate BI-CON-02 | |||
| Phosphaplatin PT-112 | |||
| Retinol | |||
| Vonlerolizumab | |||
| Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715 | |||
| Picrasinoside H | |||
| At 211 Monoclonal Antibody 81C6 | |||
| Light-activated AU-011 | |||
| ATM Kinase Inhibitor AZD1390 | |||
| Crystalline Genistein Formulation AXP107-11 | |||
| Cyclodextrin-Based Polymer-Camptothecin CRLX101 | |||
| cFMS Tyrosine Kinase Inhibitor ARRY-382 | |||
| Gold Sodium Thiomalate | |||
| Anti-CSF1R Monoclonal Antibody SNDX-6352 | |||
| p53-HDM2 Protein-protein Interaction Inhibitor APG-115 | |||
| Gefitinib | |||
| Losoxantrone | |||
| Cetuximab Sarotalocan | |||
| SIRPa-4-1BBL Fusion Protein DSP107 | |||
| Artemether Sublingual Spray | |||
| DNMT1 Inhibitor NTX-301 | |||
| Lacutamab | |||
| Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901 | |||
| I 131 Monoclonal Antibody CC49 | |||
| Shared Anti-Idiotype-AB-S024A | |||
| Docetaxel-loaded Nanopharmaceutical CRLX301 | |||
| Gamma-Secretase Inhibitor RO4929097 | |||
| CAIX Inhibitor DTP348 | |||
| Antibody-drug Conjugate ABBV-176 | |||
| Anti-CD22 ADC TRPH-222 | |||
| Glutaminase Inhibitor CB-839 | |||
| FAP/4-1BB-targeting Fusion Protein RO7122290 | |||
| Anti-PKN3 siRNA Atu027 | |||
| Tris-acryl Gelatin Microspheres | |||
| Domatinostat | |||
| Lurtotecan | |||
| Allogeneic Melanoma Vaccine AGI-101H | |||
| RAF Kinase Inhibitor XL281 | |||
| Lutetium Lu-177 Girentuximab | |||
| Lontucirev | |||
| Lapatinib | |||
| Fascin Inhibitor NP-G2-044 | |||
| Pyridyl Cyanoguanidine CHS 828 | |||
| Autologous Anti-BCMA CAR T-cells PHE885 | |||
| Elsamitrucin | |||
| HDAC Inhibitor AR-42 | |||
| Macimorelin | |||
| Bicalutamide | |||
| Lyophilized Black Raspberry Saliva Substitute | |||
| Pentamethylmelamine | |||
| Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a | |||
| Recombinant Interleukin-13 | |||
| Rilimogene Glafolivec | |||
| Pirfenidone | |||
| Androgen Receptor Downregulator AZD3514 | |||
| Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241 | |||
| Agonistic Anti-CD40 Monoclonal Antibody ADC-1013 | |||
| Anti-EGFR/CD16A Bispecific Antibody AFM24 | |||
| Glutamine Antagonist DRP-104 | |||
| Marizomib | |||
| Fresolimumab | |||
| Thioguanine | |||
| Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes | |||
| Yttrium Y 90 Monoclonal Antibody BrE-3 | |||
| PARP 1/2 Inhibitor IMP4297 | |||
| Tyrosinase Peptide | |||
| Trimethylcolchicinic Acid | |||
| Anti-CD33/CD3 Bispecific Antibody GEM 333 | |||
| SHP2 Inhibitor JAB-3068 | |||
| PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231 | |||
| Methionine Aminopeptidase 2 Inhibitor M8891 | |||
| Autologous CD19-targeted CAR T Cells JWCAR029 | |||
| Limonene, (+)- | |||
| FGFR/CSF-1R Inhibitor 3D185 | |||
| Archexin | |||
| Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017 | |||
| Flt3/MerTK Inhibitor MRX-2843 | |||
| Antineoplastic Agent Combination SM-88 | |||
| Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1 | |||
| KRAS-MAPK Signaling Pathway Inhibitor JAB-3312 | |||
| Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110 | |||
| Combretastatin A-1 | |||
| Sorghum bicolor Supplement | |||
| Raltitrexed | |||
| Monoclonal Antibody E2.3 | |||
| Misonidazole | |||
| Vesigenurtucel-L | |||
| Antitumor B Key Active Component-alpha | |||
| Prednimustine | |||
| Lutetium Lu 177 Dotatate | |||
| Pladienolide Derivative E7107 | |||
| Tyrosine Kinase Inhibitor XL228 | |||
| EP2/EP4 Antagonist TPST-1495 | |||
| Mitoguazone | |||
| Monoclonal Antibody m170 | |||
| p300/CBP Bromodomain Inhibitor CCS1477 | |||
| Liposome-encapsulated TAAs mRNA Vaccine W_ova1 | |||
| MMP Inhibitor S-3304 | |||
| Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076 | |||
| Fluoxymesterone | |||
| Rhenium Re-188 Ethiodized Oil | |||
| Liposomal Docetaxel | |||
| Bruceanol G | |||
| Aryl Hydrocarbon Receptor Antagonist BAY2416964 | |||
| Polyamine Analogue SBP-101 | |||
| Anti-Glypican 3/CD3 Bispecific Antibody ERY974 | |||
| Transferrin-CRM107 | |||
| Lutetium Lu 177 Monoclonal Antibody CC49 | |||
| Metformin | |||
| Docetaxel Emulsion ANX-514 | |||
| Imalumab | |||
| huBC1-huIL12 Fusion Protein AS1409 | |||
| Lutetium Lu 177 DOTA-biotin | |||
| Elmustine | |||
| Duvortuxizumab | |||
| Anti-CD19/CD3 Tetravalent Antibody AFM11 | |||
| Aspacytarabine | |||
| Aprutumab | |||
| Globo H-DT Vaccine OBI-833 | |||
| Anti-CD38 Monoclonal Antibody TAK-079 | |||
| Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752 | |||
| Talimogene Laherparepvec | |||
| Abemaciclib Mesylate | |||
| Hsp90 Inhibitor MPC-3100 | |||
| Lysine-specific Demethylase 1 Inhibitor INCB059872 | |||
| Autologous Anti-CD19 CAR T-cells IM19 | |||
| Anti-CTLA-4 Monoclonal Antibody HBM4003 | |||
| Retrovector Encoding Mutant Anti-Cyclin G1 | |||
| Aurora Kinase Inhibitor AMG 900 | |||
| MDM2 Inhibitor AMGMDS3 | |||
| Sustained-release Mitomycin C Hydrogel Formulation UGN-102 | |||
| Ezabenlimab | |||
| c-Met Inhibitor AMG 337 | |||
| BMS-184476 | |||
| Lyophilized Black Raspberry Lozenge | |||
| Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801 | |||
| Tyrosinase-KLH | |||
| Saracatinib Difumarate | |||
| Iroplact | |||
| Immunocytokine NHS-IL12 | |||
| Navicixizumab | |||
| Vinfosiltine | |||
| Coenzyme Q10 | |||
| O-Chloroacetylcarbamoylfumagillol | |||
| Phenesterin | |||
| Tinostamustine | |||
| Zebularine | |||
| Selonsertib | |||
| HPV6/11-targeted DNA Plasmid Vaccine INO-3107 | |||
| DACH Polymer Platinate AP5346 | |||
| Antibody-drug Conjugate SC-005 | |||
| Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794 | |||
| Anti-CD20 Monoclonal Antibody MIL62 | |||
| c-Met Inhibitor MK2461 | |||
| Methoxyamine Hydrochloride | |||
| Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum | |||
| Erdafitinib | |||
| SIRPa-Fc-CD40L Fusion Protein SL-172154 | |||
| Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315 | |||
| Hsp90 Inhibitor SNX-5422 Mesylate | |||
| Monoclonal Antibody CEP-37250/KHK2804 | |||
| Mezagitamab | |||
| Pexidartinib | |||
| Histrelin Acetate | |||
| Zorubicin Hydrochloride | |||
| Orantinib | |||
| Multi-kinase Inhibitor XL092 | |||
| Avitinib Maleate | |||
| Anti-HER-2 Bispecific Antibody KN026 | |||
| Deoxycytidine Analogue TAS-109 | |||
| Ripretinib | |||
| Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T | |||
| Soy Isoflavones | |||
| Axatilimab | |||
| Imexon | |||
| Zalutumumab | |||
| Dinaciclib | |||
| Anti-ILT4 Monoclonal Antibody MK-4830 | |||
| Enloplatin | |||
| Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01 | |||
| Alefacept | |||
| Autologous CD19-targeted CAR-T Cells GC007F | |||
| Tasquinimod | |||
| Etoglucid | |||
| AKT 1/2 Inhibitor BAY1125976 | |||
| BCMA/CD3e Tri-specific T-cell Activating Construct HPN217 | |||
| Monoclonal Antibody huJ591 | |||
| Topotecan Hydrochloride Liposomes | |||
| HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131 | |||
| Ribonuclease QBI-139 | |||
| Monoclonal Antibody 14G2A | |||
| Tegavivint | |||
| Receptor Tyrosine Kinase Inhibitor R1530 | |||
| HDM2 Inhibitor MK-8242 | |||
| Cinacalcet Hydrochloride | |||
| Numidargistat | |||
| PRMT1 Inhibitor GSK3368715 | |||
| Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404 | |||
| Anti-AG7 Antibody Drug Conjugate AbGn-107 | |||
| Amrubicin | |||
| Yttrium-90 Polycarbonate Brachytherapy Plaque | |||
| Anti-c-MET Monoclonal Antibody LY2875358 | |||
| Anti-CD123/CD3 Bispecific Antibody APVO436 | |||
| Anti-HER2 Antibody-drug Conjugate DP303c | |||
| Aminoflavone Prodrug AFP464 | |||
| Nifurtimox | |||
| Wnt Signaling Pathway Inhibitor SM08502 | |||
| CD73 Inhibitor AB680 | |||
| Naratuximab Emtansine | |||
| Allogeneic Anti-CD20-CAR T-cells PBCAR20A | |||
| Anti-EGFR Monoclonal Antibody GC1118 | |||
| Anti-CD98 Monoclonal Antibody IGN523 | |||
| Nadofaragene Firadenovec | |||
| Anti-CD33 Monoclonal Antibody BI 836858 | |||
| Bruceanol H | |||
| Letrozole | |||
| PGG Beta-Glucan | |||
| Fumagillin-Derived Polymer Conjugate XMT-1107 | |||
| Doxorubicin-Eluting Beads | |||
| Anti-HER2 ADC DS-8201a | |||
| STING Agonist MK-1454 | |||
| Durvalumab | |||
| Rogletimide | |||
| Fimaporfin A | |||
| Pexmetinib | |||
| Aurora Kinase Inhibitor MLN8054 | |||
| Peplomycin Sulfate | |||
| Shark Cartilage Extract AE-941 | |||
| Denileukin Diftitox | |||
| CDC7 Inhibitor TAK-931 | |||
| Autologous Mesenchymal Stem Cells Apceth_101 | |||
| Fenebrutinib | |||
| p97 Inhibitor CB-5339 Tosylate | |||
| Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803 | |||
| HDAC Inhibitor MPT0E028 | |||
| Ixabepilone | |||
| Yangzheng Xiaoji Extract | |||
| Synthetic hTERT DNA Vaccine INO-1401 | |||
| Recombinant MIP1-alpha Variant ECI301 | |||
| mRNA-based Personalized Cancer Vaccine mRNA-4157 | |||
| Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo | |||
| Mutant p53 Activator COTI-2 | |||
| Transferrin Receptor-Targeted Liposomal p53 cDNA | |||
| Enpromate | |||
| Barasertib | |||
| Trastuzumab/Hyaluronidase-oysk | |||
| PLK1 Inhibitor TAK-960 | |||
| Anti-c-Met Antibody-drug Conjugate HTI-1066 | |||
| DHA-Paclitaxel | |||
| Picropodophyllin | |||
| Tilogotamab | |||
| Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A | |||
| MDM2 Antagonist RO6839921 | |||
| Vinorelbine Tartrate | |||
| Caffeic Acid Phenethyl Ester | |||
| Degarelix | |||
| MAGE-A3-specific Immunotherapeutic GSK 2132231A | |||
| Topotecan Sustained-release Episcleral Plaque | |||
| Fosbretabulin | |||
| ChiNing Decoction | |||
| TLR7 agonist BNT411 | |||
| Aminopterin | |||
| HCV DNA Vaccine INO-8000 | |||
| Allogeneic Anti-CD19-CAR T-cells PBCAR0191 | |||
| Methylprednisolone | |||
| EGFR Inhibitor AZD3759 | |||
| Lucitanib | |||
| PI3K-delta Inhibitor AMG 319 | |||
| Prednisolone | |||
| Androgen Receptor Antisense Oligonucleotide AZD5312 | |||
| pan-HER Kinase Inhibitor AC480 | |||
| Axitinib | |||
| Mucoadhesive Paclitaxel Formulation | |||
| Exatecan Mesylate Anhydrous | |||
| Nimodipine | |||
| Ingenol Mebutate Gel | |||
| Tin Ethyl Etiopurpurin | |||
| Anti-B7H3 Antibody-drug Conjugate MGC018 | |||
| Azintuxizumab Vedotin | |||
| Oral Sodium Phenylbutyrate | |||
| MDM2 Antagonist RO5045337 | |||
| Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine | |||
| Autologous CD123-4SCAR-expressing T-cells 4SCAR123 | |||
| Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 | |||
| Clomiphene Citrate | |||
| Lorvotuzumab Mertansine | |||
| Plozalizumab | |||
| Nab-paclitaxel | |||
| Multifunctional/Multitargeted Anticancer Agent OMN54 | |||
| Yttrium Y-90 Epratuzumab Tetraxetan | |||
| Maekmoondong-tang | |||
| Monoclonal Antibody L6 | |||
| Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282 | |||
| Anti-PD-1/CTLA-4 Bispecific Antibody AK104 | |||
| LSD1 Inhibitor SYHA1807 | |||
| Anti-gpA33/CD3 Monoclonal Antibody MGD007 | |||
| Demcizumab | |||
| Anti-APRIL Monoclonal Antibody BION-1301 | |||
| HAAH Lambda phage Vaccine SNS-301 | |||
| CCR2 Antagonist PF-04136309 | |||
| Carboquone | |||
| Oral Milataxel | |||
| Anti-CD166 Probody-drug Conjugate CX-2009 | |||
| Buparlisib | |||
| IRAK4 Inhibitor CA-4948 | |||
| Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter | |||
| Fedratinib | |||
| EGFR/HER2 Inhibitor AV-412 | |||
| CDK7 Inhibitor SY-1365 | |||
| Oblimersen Sodium | |||
| Topoisomerase I/II Inhibitor NEV-801 | |||
| Efizonerimod | |||
| Ad-RTS-hIL-12 | |||
| Galarubicin | |||
| Erlotinib | |||
| Dolastatin 15 | |||
| Phenytoin Sodium | |||
| Autologous Anti-CD19 T-cell Receptor T cells ET190L1 | |||
| Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC | |||
| Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine | |||
| BET Inhibitor CC-90010 | |||
| Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536 | |||
| Polyunsaturated Fatty Acid | |||
| Anti-PRAME Immunotherapeutic GSK2302032A | |||
| Combretastatin | |||
| Chaparrinone | |||
| WT1 Peptide Vaccine OCV-501 | |||
| Valecobulin | |||
| EphA2-targeting Bicycle Toxin Conjugate BT5528 | |||
| Antisense Oligonucleotide GTI-2040 | |||
| Ketoconazole | |||
| Renal Cell Carcinoma Peptides Vaccine IMA901 | |||
| Pixantrone Dimaleate | |||
| Coriolus Versicolor Extract | |||
| Roneparstat | |||
| p38 MAPK Inhibitor LY3007113 | |||
| Anti-CD46 Antibody-drug Conjugate FOR46 | |||
| CDK4/6 Inhibitor FCN-437 | |||
| Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907 | |||
| Anti-GRP78 Monoclonal Antibody PAT-SM6 | |||
| Diazooxonorleucine | |||
| Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells | |||
| Vapreotide | |||
| Tivantinib | |||
| Nucleolin Antagonist IPP-204106N | |||
| STING-expressing E. coli SYNB1891 | |||
| Factor VII-targeting Immunoconjugate Protein ICON-1 | |||
| Nutraceutical TBL-12 | |||
| Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105 | |||
| Vemurafenib | |||
| Vanucizumab | |||
| FGFR Inhibitor ASP5878 | |||
| Colorectal Tumor-Associated Peptides Vaccine IMA910 | |||
| Magnesium Valproate | |||
| PEP-3-KLH Conjugate Vaccine | |||
| Tasisulam Sodium | |||
| Adenoviral MUC1 Vaccine ETBX-061 | |||
| Perifosine | |||
| Denintuzumab Mafodotin | |||
| Bruceantin | |||
| Epirubicin | |||
| Aurora Kinase Inhibitor BI 811283 | |||
| PI3Kalpha Inhibitor AZD8835 | |||
| LMB-1 Immunotoxin | |||
| Oleandrin | |||
| Macitentan | |||
| Strontium Chloride Sr-89 | |||
| Mercaptopurine Anhydrous | |||
| Anti-PSCA Monoclonal Antibody AGS-1C4D4 | |||
| Spirogermanium | |||
| Cancell | |||
| Apaziquone | |||
| Pyruvate Kinase M2 Isoform Activator TP-1454 | |||
| Sonepcizumab | |||
| CYP11A1 Inhibitor ODM-209 | |||
| HIF-1alpha Inhibitor PX-478 | |||
| Ombrabulin | |||
| Cesalin | |||
| Anti-CD20 Monoclonal Antibody BAT4306F | |||
| Personalized Neoantigen DNA Vaccine GNOS-PVO2 | |||
| FLT3 Inhibitor HM43239 | |||
| PI3Kdelta Inhibitor GS-9901 | |||
| MAT2A Inhibitor AG-270 | |||
| CDK4/6 Inhibitor BPI-16350 | |||
| Oncolytic Newcastle Disease Virus Strain PV701 | |||
| FLT3/FGFR Dual Kinase Inhibitor MAX-40279 | |||
| Wee1 Inhibitor ZN-c3 | |||
| Anti-CD205 Antibody-drug Conjugate OBT076 | |||
| Imatinib | |||
| Oltipraz | |||
| Unknown | |||
| Recombinant Transforming Growth Factor-Beta | |||
| Caricotamide/Tretazicar | |||
| Methylcantharidimide | |||
| Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200 | |||
| Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL | |||
| Anti-CD47 ADC SGN-CD47M | |||
| Hyaluronidase-zzxf/Pertuzumab/Trastuzumab | |||
| Anti-GITR Agonistic Monoclonal Antibody INCAGN01876 | |||
| FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999 | |||
| Trabectedin | |||
| Scopoletin | |||
| Anti-PD-1 Monoclonal Antibody HLX10 | |||
| Recombinant Interleukin-18 | |||
| HDAC Class I/IIb Inhibitor HG146 | |||
| Platinum Compound | |||
| Ruthenium-based Small Molecule Therapeutic BOLD-100 | |||
| Aurora Kinase Inhibitor PF-03814735 | |||
| Anti-S15 Monoclonal Antibody NC318 | |||
| Lestaurtinib | |||
| Axl/Mer Inhibitor INCB081776 | |||
| Hydrocortisone Sodium Succinate | |||
| Trimetrexate Glucuronate | |||
| Anti-CD37 Bispecific Monoclonal Antibody GEN3009 | |||
| Fosquidone | |||
| Ashwagandha Root Powder Extract | |||
| Thymidylate Synthase Inhibitor CX1106 | |||
| Sodium Stibogluconate | |||
| Thalicarpine | |||
| Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806 | |||
| Androgen Receptor Antagonist TRC253 | |||
| Liposome-encapsulated miR-34 Mimic MRX34 | |||
| Ubidecarenone Nanodispersion BPM31510n | |||
| Autologous TCR-engineered T-cells IMA202 | |||
| Yttrium Y 90 Colloid | |||
| MVA-FCU1 TG4023 | |||
| Tocotrienol | |||
| BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351 | |||
| Ridaforolimus | |||
| DM-CHOC-PEN | |||
| MET Kinase Inhibitor OMO-1 | |||
| Interleukin Therapy | |||
| Dasatinib | |||
| Eribulin Mesylate | |||
| Micro Needle Array-Doxorubicin | |||
| Anlotinib Hydrochloride | |||
| Dezapelisib | |||
| Suramin | |||
| FLT3 Inhibitor SKI-G-801 | |||
| Vibostolimab | |||
| Ketotrexate | |||
| IDO1/TDO2 Inhibitor M4112 | |||
| Anti-PD-1 Monoclonal Antibody AK105 | |||
| Nimustine Hydrochloride | |||
| Procaspase Activating Compound-1 VO-100 | |||
| EZH1/2 Inhibitor HH2853 | |||
| Pazopanib Hydrochloride | |||
| Sabarubicin | |||
| Ganglioside GM2 | |||
| Rodorubicin | |||
| Pegzilarginase | |||
| Everolimus | |||
| Glutaminase Inhibitor IPN60090 | |||
| Selumetinib Sulfate | |||
| Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine | |||
| Ranpirnase | |||
| Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY) | |||
| Repotrectinib | |||
| Anti-PD-L1 Monoclonal Antibody GR1405 | |||
| Anti-MUC16/CD3 Bispecific Antibody REGN4018 | |||
| Vulinacimab | |||
| Anti-CD123/CD3 BiTE Antibody SAR440234 | |||
| CEA-MUC-1-TRICOM Vaccine CV301 | |||
| Arugula Seed Powder | |||
| Gemcitabine Prodrug LY2334737 | |||
| Boanmycin Hydrochloride | |||
| Mosunetuzumab | |||
| Dalotuzumab | |||
| Enclomiphene | |||
| Tubulin Binding Agent TTI-237 | |||
| Sargramostim | |||
| THL-P | |||
| Cidan Herbal Capsule | |||
| mTOR Kinase Inhibitor PP242 | |||
| D-methionine Formulation MRX-1024 | |||
| Anti-OFA Immunotherapeutic BB-MPI-03 | |||
| Talabostat | |||
| Cediranib | |||
| SNS01-T Nanoparticles | |||
| Dibrospidium Chloride | |||
| 3'-dA Phosphoramidate NUC-7738 | |||
| Paclitaxel PPE Microspheres | |||
| Anti-Ep-CAM Monoclonal Antibody ING-1 | |||
| Luminespib | |||
| FGFR2 Inhibitor RLY-4008 | |||
| Lanreotide Acetate | |||
| TGF-beta Receptor 1 Kinase Inhibitor SH3051 | |||
| Cosibelimab | |||
| Capecitabine Rapidly Disintegrating Tablet | |||
| Apoptosis Inducer MPC-2130 | |||
| Bazedoxifene | |||
| ATM Inhibitor M 3541 | |||
| Sodium Phenylbutyrate | |||
| PAK4/NAMPT Inhibitor KPT-9274 | |||
| BET inhibitor BI 894999 | |||
| Tubulin Polymerization Inhibitor VERU-111 | |||
| PI3K-delta Inhibitor INCB050465 | |||
| Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101 | |||
| Pan-PIM Inhibitor INCB053914 | |||
| Anti-B7-H3 Antibody DS-5573a | |||
| DNA Minor Groove Binding Agent SG2000 | |||
| DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555 | |||
| Triapine | |||
| Zuclomiphene Citrate | |||
| Dexamethasone Phosphate | |||
| TP40 Immunotoxin | |||
| Marimastat | |||
| Retaspimycin Hydrochloride | |||
| Pegylated Liposomal Doxorubicin Hydrochloride | |||
| Anti-PD-L1 Monoclonal Antibody CBT-502 | |||
| Digitoxin | |||
| Autologous Anti-CD19/CD22 CAR T-cells AUTO3 | |||
| IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1 | |||
| Cladribine | |||
| Anti-TWEAK Monoclonal Antibody RG7212 | |||
| Brivanib Alaninate | |||
| Axicabtagene Ciloleucel | |||
| Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation | |||
| Vibecotamab | |||
| EGFR T790M Inhibitor HS-10296 | |||
| Androgen Receptor Antagonist SHR3680 | |||
| Anti-Claudin18.2 Monoclonal Antibody TST001 | |||
| Thalidomide | |||
| pan-PI3K/mTOR Inhibitor SF1126 | |||
| MDM2 Inhibitor BI 907828 | |||
| Hu14.18-IL2 Fusion Protein EMD 273063 | |||
| Roquinimex | |||
| Noscapine Hydrochloride | |||
| Ormaplatin | |||
| Hsp90-targeted Photosensitizer HS-201 | |||
| Emitefur | |||
| Edrecolomab | |||
| Navoximod | |||
| Monoclonal Antibody 3F8 | |||
| Telaglenastat | |||
| SERD ZN-c5 | |||
| Tetraphenyl Chlorin Disulfonate | |||
| Floxuridine | |||
| pan-RAF Kinase Inhibitor CCT3833 | |||
| Emepepimut-S | |||
| DKK1-Neutralizing Monoclonal Antibody DKN-01 | |||
| Maraba Oncolytic Virus Expressing Mutant HPV E6/E7 | |||
| VLP-encapsulated TLR9 Agonist CMP-001 | |||
| Jin Fu Kang | |||
| Vinflunine | |||
| Colorectal Cancer Peptide Vaccine PolyPEPI1018 | |||
| Oxeclosporin | |||
| Lenalidomide Analog KPG-121 | |||
| Octreotide Pamoate | |||
| Sho-Saiko-To | |||
| Mitazalimab | |||
| Ruthenium-based Transferrin Targeting Agent NKP-1339 | |||
| Gemcitabine Hydrochloride | |||
| Relugolix | |||
| Combretastatin A1 Diphosphate | |||
| AEE788 | |||
| IMT-1012 Immunotherapeutic Vaccine | |||
| Immune Checkpoint Inhibitor ASP8374 | |||
| Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931 | |||
| Lutetium Lu 177-PSMA-617 | |||
| Compound Kushen Injection | |||
| Nelipepimut-S Plus GM-CSF Vaccine | |||
| Polo-like Kinase 1 Inhibitor GSK461364 | |||
| Linifanib | |||
| Litronesib | |||
| IL-2 Recombinant Fusion Protein ALT-801 | |||
| Chk1 Inhibitor CCT245737 | |||
| FGF Receptor Antagonist HGS1036 | |||
| FLT3/ABL/Aurora Kinase Inhibitor KW-2449 | |||
| Triamcinolone Acetonide | |||
| A2A Receptor Antagonist EOS100850 | |||
| Anti-HER2 Antibody-drug Conjugate BAT8001 | |||
| CD80-Fc Fusion Protein ALPN-202 | |||
| Cortisone Acetate | |||
| Medroxyprogesterone Acetate | |||
| Nilotinib | |||
| Trimetrexate | |||
| Iadademstat | |||
| Aurora Kinase Inhibitor SNS-314 | |||
| Bermekimab | |||
| Camptothecin Analogue TLC388 | |||
| Zanolimumab | |||
| Losatuxizumab Vedotin | |||
| Ovine Submaxillary Mucin | |||
| Smac Mimetic GDC-0917 | |||
| Bruceanol D | |||
| Golnerminogene Pradenovec | |||
| P-cadherin Antagonist PF-03732010 | |||
| JAK Inhibitor | |||
| Recombinant Leukocyte Interleukin | |||
| Proxalutamide | |||
| Pegylated Deoxycytidine Analogue DFP-14927 | |||
| MAGE-A3 Multipeptide Vaccine GL-0817 | |||
| Piritrexim Isethionate | |||
| Testolactone | |||
| Topoisomerase I Inhibitor LMP400 | |||
| Elpamotide | |||
| Mapatumumab | |||
| L-Gossypol | |||
| Tandutinib | |||
| Ripertamab | |||
| Lenzilumab | |||
| Anti-gremlin-1 Monoclonal Antibody UCB6114 | |||
| Pegylated Recombinant Interleukin-2 THOR-707 | |||
| Cordycepin Triphosphate | |||
| Amblyomin-X | |||
| Puquitinib | |||
| SERD SAR439859 | |||
| Ixazomib | |||
| Cabiralizumab | |||
| Iodine I 131 Tositumomab | |||
| Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240 | |||
| Recombinant Interferon Alfa-2b | |||
| CXCR4 Peptide Antagonist LY2510924 | |||
| Iodine I 131 Tenatumomab | |||
| Ocrelizumab | |||
| Viagenpumatucel-L | |||
| Tozasertib Lactate | |||
| Antibody-drug Conjugate ABBV-838 | |||
| Antibody-drug Conjugate SC-007 | |||
| Anti-PVRIG Monoclonal Antibody COM701 | |||
| Alvespimycin Hydrochloride | |||
| Seribantumab | |||
| Clofarabine | |||
| mTOR Kinase Inhibitor CC-223 | |||
| Noscapine | |||
| Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736 | |||
| PARP-1/2 Inhibitor ABT-767 | |||
| USP14/UCHL5 Inhibitor VLX1570 | |||
| Monoclonal Antibody TRK-950 | |||
| IGF-1R Inhibitor | |||
| Autologous CD38-4SCAR-expressing T-cells 4SCAR38 | |||
| Anti-HER2 Antibody-drug Conjugate A166 | |||
| Rivoceranib Mesylate | |||
| Oncolytic HSV1716 | |||
| SIRPa-Fc Fusion Protein TTI-621 | |||
| Menatetrenone | |||
| Plk1 Inhibitor BI 2536 | |||
| Vantictumab | |||
| Dactolisib Tosylate | |||
| Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19 | |||
| Galectin Inhibitor GR-MD-02 | |||
| Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301 | |||
| Cevipabulin Fumarate | |||
| Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A | |||
| Entinostat | |||
| Algenpantucel-L | |||
| HER2 Tri-specific Natural Killer Cell Engager DF1001 | |||
| Oral Topotecan Hydrochloride | |||
| Taurultam | |||
| Seclidemstat | |||
| Antiangiogenic Drug Combination TL-118 | |||
| Hemiasterlin Analog E7974 | |||
| Glioma Lysate Vaccine GBM6-AD | |||
| Osilodrostat | |||
| iNKT Cell Agonist ABX196 | |||
| Phosphorodiamidate Morpholino Oligomer AVI-4126 | |||
| Checkpoint Kinase Inhibitor XL844 | |||
| WT1 Protein-derived Peptide Vaccine DSP-7888 | |||
| Sotrastaurin Acetate | |||
| Anti-CD38 Antibody-drug Conjugate STI-6129 | |||
| Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342 | |||
| Anti-PD-L1 Monoclonal Antibody BGB-A333 | |||
| Monoclonal Antibody Lym-1 | |||
| TLR-Directed Cationic Lipid-DNA Complex JVRS-100 | |||
| Peptide 946 Melanoma Vaccine | |||
| Anti-FLT3 Monoclonal Antibody 4G8-SDIEM | |||
| Oral Microencapsulated Diindolylmethane | |||
| Enclomiphene Citrate | |||
| Thymidylate Synthase Inhibitor DFP-11207 | |||
| IL-10 Immunomodulator MK-1966 | |||
| CDC7 Kinase Inhibitor LY3143921 Hydrate | |||
| Pegaspargase | |||
| CDK2 Inhibitor PF-07104091 | |||
| Bacillus Calmette-Guerin Substrain Connaught Live Antigen | |||
| Tanomastat | |||
| Liposomal SN-38 | |||
| ALK Inhibitor PLB 1003 | |||
| Ropocamptide | |||
| Diphencyprone | |||
| Teroxirone | |||
| Olvimulogene Nanivacirepvec | |||
| Monoclonal Antibody A27.15 | |||
| Rezivertinib | |||
| Mafosfamide | |||
| Stallimycin | |||
| DNA Vaccine VB10.16 | |||
| CD40 Agonistic Monoclonal Antibody APX005M | |||
| Tazarotene | |||
| TRPM8 Agonist D-3263 | |||
| LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes | |||
| Recombinant CD40-Ligand | |||
| Anti-CEACAM1 Monoclonal Antibody CM-24 | |||
| Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752 | |||
| Qilisheng Immunoregulatory Oral Solution | |||
| Cytidine Analog RX-3117 | |||
| Cyproterone | |||
| Sevacizumab | |||
| P-cadherin-targeting Agent PF-06671008 | |||
| mTORC1/2 Kinase Inhibitor BI 860585 | |||
| Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine | |||
| Rivoceranib | |||
| Autologous CD19-targeted CAR T Cells CC-97540 | |||
| Tolnidamine | |||
| Adagloxad Simolenin | |||
| Lifileucel | |||
| Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841 | |||
| Anti-LAG-3 Monoclonal Antibody INCAGN02385 | |||
| Thorium Th 227 Anetumab Corixetan | |||
| Pegylated Recombinant L-asparaginase Erwinia chrysanthemi | |||
| pan-RAF Inhibitor LXH254 | |||
| BET Bromodomain Inhibitor ZEN-3694 | |||
| Poliglusam | |||
| PI3K-delta Inhibitor HMPL 689 | |||
| Smoothened Antagonist TAK-441 | |||
| p70S6K Inhibitor LY2584702 | |||
| Triptolide Analog | |||
| Anakinra | |||
| Androstane Steroid HE3235 | |||
| Porcupine Inhibitor WNT974 | |||
| mRNA-based TriMix Melanoma Vaccine ECI-006 | |||
| Amustaline Dihydrochloride | |||
| Cytarabine | |||
| Alpha-Thioguanine Deoxyriboside | |||
| Anti-BCMA/PBD ADC MEDI2228 | |||
| Zinc Finger Nuclease ZFN-758 | |||
| Motesanib Diphosphate | |||
| Y 90 Monoclonal Antibody M195 | |||
| Liposome-Encapsulated Doxorubicin Citrate | |||
| Multi-neo-epitope Vaccine OSE 2101 | |||
| Alisertib | |||
| Baltaleucel-T | |||
| Sipuleucel-T | |||
| Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 | |||
| Glembatumumab Vedotin | |||
| KRAS Mutant-targeting AMG 510 | |||
| Anti-5T4 Antibody-drug Conjugate ASN004 | |||
| SSTR2-targeting Protein/DM1 Conjugate PEN-221 | |||
| Alflutinib Mesylate | |||
| Taxane Analogue TPI 287 | |||
| Essiac | |||
| Phenethyl Isothiocyanate-containing Watercress Juice | |||
| Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428 | |||
| Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306 | |||
| Oncolytic Newcastle Disease Virus MEDI5395 | |||
| Oxidative Phosphorylation Inhibitor IACS-010759 | |||
| ALK-FAK Inhibitor CEP-37440 | |||
| Smac Mimetic LCL161 | |||
| IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051 | |||
| Piritrexim | |||
| Glecaprevir/Pibrentasvir | |||
| Triplatin Tetranitrate | |||
| Interleukin-12-Fc Fusion Protein DF6002 | |||
| Pibrozelesin | |||
| PI3K Inhibitor GSK1059615 | |||
| Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A | |||
| 2-O, 3-O Desulfated Heparin | |||
| Varlilumab | |||
| Emibetuzumab | |||
| PVA Microporous Hydrospheres/Doxorubicin Hydrochloride | |||
| Anti-ANG2 Monoclonal Antibody MEDI-3617 | |||
| Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181 | |||
| SHP2 Inhibitor RMC-4630 | |||
| Lometrexol Sodium | |||
| Bromacrylide | |||
| DNA-PK inhibitor AZD7648 | |||
| Metformin Hydrochloride | |||
| Anti-PRL-3 Monoclonal Antibody PRL3-zumab | |||
| Trapoxin | |||
| Vitamin E Compound | |||
| Anti-GITR Monoclonal Antibody MK-4166 | |||
| Dianhydrogalactitol | |||
| Anti-PD-1 Monoclonal Antibody F520 | |||
| N,N-Dibenzyl Daunomycin | |||
| Bleomycin | |||
| I 131 Monoclonal Antibody A33 | |||
| Thioguanine Anhydrous | |||
| Alvocidib Prodrug TP-1287 | |||
| Engineered Toxin Body Targeting HER2 MT-5111 | |||
| Sorafenib | |||
| Chlorotoxin | |||
| Lifirafenib | |||
| Elagolix | |||
| GITR Agonist MEDI1873 | |||
| Darolutamide | |||
| DNA-dependent Protein Kinase Inhibitor VX-984 | |||
| MDM2/MDMX Inhibitor ALRN-6924 | |||
| Binimetinib | |||
| Bcl-Xs Adenovirus Vaccine | |||
| Tocilizumab | |||
| PI3K-beta Inhibitor GSK2636771 | |||
| Black Cohosh | |||
| Refametinib | |||
| IDO Peptide Vaccine IO102 | |||
| Vincristine Sulfate Liposome | |||
| Carbetimer | |||
| Lisocabtagene Maraleucel | |||
| Cinobufagin | |||
| Personalized Cancer Vaccine RO7198457 | |||
| Idarubicin-Eluting Beads | |||
| Anti-HGF Monoclonal Antibody TAK-701 | |||
| CXCR4/E-selectin Antagonist GMI-1359 | |||
| Sibrotuzumab | |||
| KSP Inhibitor SB-743921 | |||
| Etoposide Phosphate | |||
| Cytochlor | |||
| Polo-like Kinase 1 Inhibitor NMS-1286937 | |||
| Lm-tLLO-neoantigens Vaccine ADXS-NEO | |||
| Alobresib | |||
| Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles | |||
| Glufosfamide | |||
| Anti-A5B1 Integrin Monoclonal Antibody PF-04605412 | |||
| Valproic Acid | |||
| Semuloparin | |||
| Maackia amurensis Seed Lectin | |||
| DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98 | |||
| Simalikalactone D | |||
| Milatuzumab | |||
| Glutaminase Inhibitor CB-839 Hydrochloride | |||
| EZH2 inhibitor CPI-0209 | |||
| Anti-CD123 Monoclonal Antibody KHK2823 | |||
| Methotrexate | |||
| Lutetium Lu 177-NeoB | |||
| Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101 | |||
| Tegafur | |||
| Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130 | |||
| TLR7 Agonist 852A | |||
| SN-38-Loaded Polymeric Micelles NK012 | |||
| Prime Cancer Vaccine MVA-BN-CV301 | |||
| Olmutinib | |||
| DAB389 Epidermal Growth Factor | |||
| Pidilizumab | |||
| Alpelisib | |||
| Syk Inhibitor HMPL-523 | |||
| Efatutazone | |||
| Autologous CD22-4SCAR-expressing T-cells 4SCAR22 | |||
| Anti-CD52 Monoclonal Antibody ALLO-647 | |||
| Anti-BCMA/CD3 BiTE Antibody AMG 701 | |||
| Anti-Ly6E Antibody-Drug Conjugate RG 7841 | |||
| Yttrium Y-90 Clivatuzumab Tetraxetan | |||
| iNOS Dimerization Inhibitor ASP9853 | |||
| Briciclib Sodium | |||
| LRP5 Antagonist BI 905681 | |||
| Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135 | |||
| Tubulin-Binding Agent SSR97225 | |||
| Entrectinib | |||
| PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1 | |||
| Indicine-N-Oxide | |||
| Anhydrovinblastine | |||
| Triamcinolone Hexacetonide | |||
| Daromun | |||
| Radioactive Iodine | |||
| Dopamine-Somatostatin Chimeric Molecule BIM-23A760 | |||
| Neratinib Maleate | |||
| CK2-targeting Synthetic Peptide CIGB-300 | |||
| Fludarabine Phosphate | |||
| Liposomal NDDP | |||
| Hexamethylene Bisacetamide | |||
| Estradiol Valerate | |||
| Paclitaxel Poliglumex | |||
| Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001 | |||
| Glasdegib Maleate | |||
| Nidanilimab | |||
| MVA-BN Smallpox Vaccine | |||
| Remetinostat | |||
| Exatecan Mesylate | |||
| Clanfenur | |||
| Clostridium Novyi-NT Spores | |||
| Recombinant Granulocyte-Macrophage Colony-Stimulating Factor | |||
| Eribulin | |||
| Simeprevir | |||
| Antroquinonol Capsule | |||
| Pipobroman | |||
| Interferon Alfa-N3 | |||
| Vorolanib | |||
| Infigratinib | |||
| Dezaguanine Mesylate | |||
| TRK Inhibitor TQB3558 | |||
| Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 | |||
| Trientine Hydrochloride | |||
| Pegylated Liposomal Belotecan | |||
| Tirapazamine | |||
| Polymeric Camptothecin Prodrug XMT-1001 | |||
| PCNU | |||
| PSA/IL-2/GM-CSF Vaccine | |||
| Roflumilast | |||
| Niraparib | |||
| Camptothecin Glycoconjugate BAY 38-3441 | |||
| MTF-1 Inhibitor APTO-253 HCl | |||
| Diindolylmethane | |||
| Mercaptopurine Oral Suspension | |||
| Vascular Disrupting Agent BNC105P | |||
| Neoantigen-based Therapeutic Cancer Vaccine GRT-R904 | |||
| Ifabotuzumab | |||
| O6-Benzylguanine | |||
| Amivantamab | |||
| BET Inhibitor GS-5829 | |||
| Capmatinib | |||
| Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424 | |||
| Acridine Carboxamide | |||
| Elotuzumab | |||
| Anti-VISTA Monoclonal Antibody JNJ 61610588 | |||
| Prostate Health Cocktail Dietary Supplement | |||
| Quinine | |||
| Lutetium Lu 177-Edotreotide | |||
| Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101 | |||
| Spongistatin | |||
| Relatlimab | |||
| Tapotoclax | |||
| Rituximab | |||
| JAK Inhibitor INCB047986 | |||
| Chloroquine | |||
| VEGFR2 Tyrosine Kinase Inhibitor PF-00337210 | |||
| Denosumab | |||
| Seneca Valley Virus-001 | |||
| Prostate Cancer Vaccine ONY-P1 | |||
| Morpholinodoxorubicin | |||
| Anti-DLL4 Monoclonal Antibody MEDI0639 | |||
| Anti-PD-L1/CD137 Bispecific Antibody MCLA-145 | |||
| Camsirubicin | |||
| Ametantrone | |||
| Sparfosic Acid | |||
| HER2-directed TLR8 Agonist SBT6050 | |||
| 2,6-Dimethoxyquinone | |||
| Henatinib Maleate | |||
| Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201 | |||
| Gemtuzumab Ozogamicin | |||
| Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE | |||
| Bendamustine | |||
| Anti-PD-L1 Monoclonal Antibody BCD-135 | |||
| H1299 Tumor Cell Lysate Vaccine | |||
| Filgrastim | |||
| Pegylated Recombinant Human Hyaluronidase PH20 | |||
| Trametinib | |||
| Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006 | |||
| Z-Endoxifen Hydrochloride | |||
| EZH2 Inhibitor PF-06821497 | |||
| Tidutamab | |||
| Trimeric GITRL-Fc OMP-336B11 | |||
| Verpasep Caltespen | |||
| Monoclonal Antibody IMMU-14 | |||
| FMS Inhibitor JNJ-40346527 | |||
| Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201 | |||
| Bispecific Antibody AMG 509 | |||
| Panobinostat Nanoparticle Formulation MTX110 | |||
| Bempegaldesleukin | |||
| Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388 | |||
| Selatinib Ditosilate | |||
| Anti-LIF Monoclonal Antibody MSC-1 | |||
| Anti-claudin18.2 Monoclonal Antibody AB011 | |||
| Ethaselen | |||
| Blueberry Powder Supplement | |||
| Itraconazole | |||
| Gamboge Resin Extract TSB-9-W1 | |||
| Anti-CD27L Antibody-Drug Conjugate AMG 172 | |||
| MKNK1 Inhibitor BAY 1143269 | |||
| Doxercalciferol | |||
| CDK1 Inhibitor BEY1107 | |||
| Carboxyphenyl Retinamide | |||
| cis-Urocanic Acid | |||
| Peldesine | |||
| MEK inhibitor CS3006 | |||
| Nutlin-3a | |||
| Plasmid DNA Vaccine pING-hHER3FL | |||
| Asulacrine Isethionate | |||
| Cemiplimab | |||
| Monoclonal Antibody 1F5 | |||
| Pyrotinib Dimaleate | |||
| Sodium Borocaptate | |||
| Samarium Sm 153-DOTMP | |||
| Inodiftagene Vixteplasmid | |||
| Xanthohumol | |||
| Afuresertib | |||
| Akt/ERK Inhibitor ONC201 | |||
| Recombinant Macrophage Colony-Stimulating Factor | |||
| Thymopentin | |||
| Pibenzimol | |||
| LMP-2:340-349 Peptide Vaccine | |||
| Anti-FLT3 Monoclonal Antibody IMC-EB10 | |||
| Rhenium Re 188 BMEDA-labeled Liposomes | |||
| Pimitespib | |||
| Quinacrine Hydrochloride | |||
| Liposomal Vinorelbine | |||
| Tasadenoturev | |||
| Topical Betulinic Acid | |||
| Anti-HER2 Antibody-drug Conjugate ARX788 | |||
| Telisotuzumab | |||
| Recombinant KSA Glycoprotein CO17-1A | |||
| Triazene Derivative CB10-277 | |||
| Anti-OX40 Antibody BMS 986178 | |||
| Niacinamide | |||
| Aurora A Kinase Inhibitor MK5108 | |||
| Extended Release Flucytosine | |||
| Anti-HLA-G Antibody TTX-080 | |||
| Dostarlimab | |||
| Dexamethasone | |||
| Imiquimod | |||
| Fursultiamine | |||
| Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439 | |||
| Lurbinectedin | |||
| Istiratumab | |||
| Anti-CD44 Monoclonal Antibody RO5429083 | |||
| Hydroxychloroquine | |||
| Bispecific Antibody 2B1 | |||
| Nagrestipen | |||
| Daratumumab/rHuPH20 | |||
| BXQ-350 Nanovesicle Formulation | |||
| BMS-188797 | |||
| Carbon C 14-pamiparib | |||
| Ecromeximab | |||
| CL 246738 | |||
| MARCKS Protein Inhibitor BIO-11006 | |||
| Monoclonal Antibody R24 | |||
| Bardoxolone Methyl | |||
| Porcupine Inhibitor CGX1321 | |||
| Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901 | |||
| Dromostanolone Propionate | |||
| RAF Kinase Inhibitor L-779450 | |||
| Buthionine Sulfoximine | |||
| Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes | |||
| Anti-CTLA-4 Monoclonal Antibody MK-1308 | |||
| Multikinase Inhibitor SAR103168 | |||
| Recombinant Leukoregulin | |||
| Photosensitizer LUZ 11 | |||
| Camptothecin-20(S)-O-Propionate Hydrate | |||
| Prostaglandin E2 EP4 Receptor Inhibitor E7046 | |||
| Aniline Mustard | |||
| Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1 | |||
| CHK1 Inhibitor MK-8776 | |||
| Pan-RAR Agonist/AP-1 Inhibitor LGD 1550 | |||
| CD123-CD33 Compound CAR T Cells | |||
| Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1 | |||
| Dupilumab | |||
| Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208 | |||
| B-Raf/VEGFR-2 Inhibitor RAF265 | |||
| Narnatumab | |||
| Larotrectinib Sulfate | |||
| BR96-Doxorubicin Immunoconjugate | |||
| Axalimogene Filolisbac | |||
| Antibody-drug Conjugate ABBV-085 | |||
| Anti-PD-1 Monoclonal Antibody BCD-100 | |||
| Interleukin-15 Fusion Protein BJ-001 | |||
| Genistein | |||
| Polyamine Analog SL11093 | |||
| Ofranergene Obadenovec | |||
| ALK/ROS1/Met Inhibitor TQ-B3101 | |||
| Belimumab | |||
| Halichondrin Analogue E7130 | |||
| DPT/BCG/Measles/Serratia/Pneumococcus Vaccine | |||
| Larotaxel | |||
| Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22 | |||
| Carbogen | |||
| Ficlatuzumab | |||
| Mavelertinib | |||
| Antibody-drug Conjugate SC-006 | |||
| Fotemustine | |||
| Oncolytic HSV-1 NV1020 | |||
| Anti-CD20/CD3 Monoclonal Antibody XmAb13676 | |||
| Cannabidiol | |||
| Annonaceous Acetogenins | |||
| Recombinant Interferon Alfa-1b | |||
| Aphidicoline Glycinate | |||
| Edicotinib | |||
| Canfosfamide Hydrochloride | |||
| p97 Inhibitor CB-5083 | |||
| Uncaria tomentosa Extract | |||
| Recombinant Transforming Growth Factor-Beta-2 | |||
| BL22 Immunotoxin | |||
| Cusatuzumab | |||
| NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611 | |||
| Rocakinogene Sifuplasmid | |||
| Smac Mimetic GDC-0152 | |||
| Azurin:50-77 Cell Penetrating Peptide p28 | |||
| ADH-1 | |||
| Etalocib | |||
| Oral Fludarabine Phosphate | |||
| Autologous ROR2-targeted CAR T-cells CCT301-59 | |||
| PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701 | |||
| 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521 | |||
| Adenoviral PSA Vaccine ETBX-071 | |||
| Margetuximab | |||
| Autologous Multi-lineage Potential Cells | |||
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125 | |||
| Oxidative Phosphorylation Inhibitor IM156 | |||
| PIM/FLT3 Kinase Inhibitor SEL24 | |||
| Obinutuzumab | |||
| Aurora B/C Kinase Inhibitor GSK1070916A | |||
| Vinepidine | |||
| Benaxibine | |||
| Daporinad | |||
| Licorice | |||
| Mitozolomide | |||
| Merbarone | |||
| Phytochlorin Sodium-Polyvinylpyrrolidone Complex | |||
| Liposome-encapsulated OSI-7904 | |||
| Melanoma Monoclonal Antibody hIgG2A | |||
| Ponatinib Hydrochloride | |||
| Mavorixafor | |||
| Raloxifene Hydrochloride | |||
| Aziridinylbenzoquinone RH1 | |||
| HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201 | |||
| S-Adenosylmethionine | |||
| Anti-CTLA-4 Monoclonal Antibody ADG116 | |||
| Seocalcitol | |||
| Selective Estrogen Receptor Degrader LY3484356 | |||
| Icrucumab | |||
| Ceralasertib | |||
| Lucanthone | |||
| EGFR/FLT3/Abl Inhibitor SKLB1028 | |||
| Fianlimab | |||
| Intoplicine | |||
| Bersanlimab | |||
| ERa36 Modulator Icaritin | |||
| Wnt Signaling Inhibitor SM04755 | |||
| RIPK1 Inhibitor GSK3145095 | |||
| Anti-PD-1 Monoclonal Antibody GLS-010 | |||
| Tocotrienol-rich Fraction | |||
| Galiximab | |||
| Merestinib | |||
| Tomaralimab | |||
| Verapamil | |||
| Polyamine Analogue PG11047 | |||
| Belapectin | |||
| HuaChanSu | |||
| Oral Aminolevulinic Acid Hydrochloride | |||
| Bcl-2 Inhibitor APG 2575 | |||
| Conbercept | |||
| Protease-activated Anti-PD-L1 Antibody Prodrug CX-072 | |||
| Dihydro-5-Azacytidine | |||
| Iodine I 131 Monoclonal Antibody muJ591 | |||
| Gatipotuzumab | |||
| Cisplatin | |||
| BRAF(V600E) Kinase Inhibitor ABM-1310 | |||
| RET Inhibitor DS-5010 | |||
| Satraplatin | |||
| Irinotecan-Eluting Beads | |||
| Anti-NaPi2b Antibody-drug Conjugate XMT-1592 | |||
| Dabrafenib Mesylate | |||
| PEOX-based Polymer Encapsulated Paclitaxel FID-007 | |||
| Tyrosine Kinase Inhibitor | |||
| CYP17/Androgen Receptor Inhibitor ODM 204 | |||
| Foritinib Succinate | |||
| Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014 | |||
| Antibody-drug Conjugate PF-06664178 | |||
| Tegafur-Uracil | |||
| Miransertib | |||
| DNA Interference Oligonucleotide PNT2258 | |||
| Metamelfalan | |||
| CK1alpha/CDK7/CDK9 Inhibitor BTX-A51 | |||
| Goserelin Acetate | |||
| Oral Docetaxel | |||
| Anti-CD19 iCAR NK Cells | |||
| Apomab | |||
| HIF-2alpha Inhibitor PT2385 | |||
| Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4 | |||
| Ipafricept | |||
| Tucatinib | |||
| Lometrexol | |||
| Mitoflaxone | |||
| Febuxostat | |||
| Edatrexate | |||
| Ethylnitrosourea | |||
| Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 | |||
| Laetrile | |||
| PR1 Leukemia Peptide Vaccine | |||
| Pirotinib | |||
| Copper Gluconate | |||
| Linsitinib | |||
| Choline Kinase Alpha Inhibitor TCD-717 | |||
| Ifosfamide | |||
| North American Ginseng Extract AFX-2 | |||
| Futuximab | |||
| HER2 Inhibitor DZD1516 | |||
| Panulisib | |||
| CYP17 Lyase Inhibitor ASN001 | |||
| Milataxel | |||
| Oncolytic Adenovirus Ad5-DNX-2401 | |||
| Mitomycin C Analog KW-2149 | |||
| Midostaurin | |||
| Autologous TCR-engineered T-cells IMA201 | |||
| BRD4 Inhibitor PLX51107 | |||
| Anti-C4.4a Antibody-Drug Conjugate BAY1129980 | |||
| Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A | |||
| Integrin alpha-2 Inhibitor E7820 | |||
| TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells | |||
| Nucleotide Analogue GS 9219 | |||
| Bavituximab | |||
| Triciribine Phosphate | |||
| Cintredekin Besudotox | |||
| Anti-FLT3/CD3 BiTE Antibody AMG 427 | |||
| IAP Inhibitor APG-1387 | |||
| Recombinant Anti-WT1 Immunotherapeutic GSK2302024A | |||
| Dolastatin 10 | |||
| 10-Deacetyltaxol | |||
| Citarinostat | |||
| Emapalumab | |||
| Canertinib Dihydrochloride | |||
| Oportuzumab Monatox | |||
| TGF-beta Receptor 1 Inhibitor PF-06952229 | |||
| Anti-CD123/CD3 Bispecific Antibody JNJ-63709178 | |||
| Anti-PD-L1 Monoclonal Antibody CS1001 | |||
| Anti-Tissue Factor Monoclonal Antibody MORAb-066 | |||
| Anti-EGFRvIII Antibody Drug Conjugate AMG 595 | |||
| Coxsackievirus A21 | |||
| Taurolidine | |||
| Sialyl Tn-KLH Vaccine | |||
| Anti-ErbB3 Monoclonal Antibody AV-203 | |||
| Epitinib Succinate | |||
| Hsp90 Inhibitor SNX-5542 Mesylate | |||
| Dacplatinum | |||
| Voxtalisib | |||
| Sacubitril/Valsartan | |||
| Acai Berry Juice | |||
| Ethinyl Estradiol | |||
| 2-Hydroxyestradiol | |||
| Vilaprisan | |||
| IGF-1R/IR Inhibitor KW-2450 | |||
| Dactinomycin | |||
| Anti-TGF-beta Monoclonal Antibody SAR-439459 | |||
| CDK4/6 Inhibitor CS3002 | |||
| Boronophenylalanine-Fructose Complex | |||
| BF-200 Gel Formulation | |||
| Exisulind | |||
| Anti-MMP-9 Monoclonal Antibody GS-5745 | |||
| Pixatimod | |||
| Green Tea Extract-based Antioxidant Supplement | |||
| Staphylococcal Enterotoxin A | |||
| Tabalumab | |||
| Natural IFN-alpha OPC-18 | |||
| Oral Cancer Vaccine V3-OVA | |||
| Incyclinide | |||
| Indatuximab Ravtansine | |||
| R-(-)-Gossypol Acetic Acid | |||
| NEDD8 Activating Enzyme E1 Inhibitor TAS4464 | |||
| Edodekin alfa | |||
| Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081 | |||
| Olaptesed Pegol | |||
| Tebentafusp | |||
| Ivaltinostat | |||
| Nucleotide Analog Prodrug NUC-3373 | |||
| Zelavespib | |||
| ERK1/2 Inhibitor HH2710 | |||
| Porfimer Sodium | |||
| Farletuzumab | |||
| Brachyury-expressing Yeast Vaccine GI-6301 | |||
| Pyrazinamide | |||
| Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 | |||
| Aurora kinase A/B inhibitor TT-00420 | |||
| Intetumumab | |||
| Aclarubicin | |||
| PI3K Inhibitor GDC0077 | |||
| HDAC6 Inhibitor KA2507 | |||
| Topotecan | |||
| Empesertib | |||
| Anti-C5aR Monoclonal Antibody IPH5401 | |||
| Ranimustine | |||
| Brontictuzumab | |||
| Tomivosertib | |||
| PI3Ka/mTOR Inhibitor PKI-179 | |||
| Nanoparticle Paclitaxel Ointment SOR007 | |||
| Anti-KSP/Anti-VEGF siRNAs ALN-VSP02 | |||
| Anti-TIM3 Monoclonal Antibody SHR-1702 | |||
| pbi-shRNA STMN1 Lipoplex | |||
| Carmustine Implant | |||
| Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 | |||
| Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046 | |||
| Bomedemstat | |||
| Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01 | |||
| Utomilumab | |||
| Tarenflurbil | |||
| Neratinib | |||
| Pseudoisocytidine | |||
| Human Monoclonal Antibody 216 | |||
| Anti-GITR Agonistic Monoclonal Antibody ASP1951 | |||
| 2'-F-ara-deoxyuridine | |||
| Anti-DR5 Agonist Monoclonal Antibody TRA-8 | |||
| Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11 | |||
| PI3K Inhibitor WX-037 | |||
| Anti-CD73 Monoclonal Antibody NZV930 | |||
| Doxorubicin-Magnetic Targeted Carrier Complex | |||
| Vinzolidine Sulfate | |||
| Anti-ErbB3 Monoclonal Antibody CDX-3379 | |||
| Ozarelix | |||
| Sorafenib Tosylate | |||
| mRNA-based Personalized Cancer Vaccine NCI-4650 | |||
| HSP90-targeted SN-38 Conjugate PEN-866 | |||
| TLR7 Agonist LHC165 | |||
| Anti-ICAM-1 Monoclonal Antibody BI-505 | |||
| Patidegib | |||
| Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564 | |||
| Patritumab | |||
| Serine/Threonine Kinase Inhibitor XL418 | |||
| Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497 | |||
| Anti-GITR Monoclonal Antibody GWN 323 | |||
| Axl/Mer Inhibitor PF-07265807 | |||
| Sugemalimab | |||
| Pelitinib | |||
| Androgen Receptor Degrader ARV-110 | |||
| MEK Inhibitor WX-554 | |||
| Rocapuldencel-T | |||
| Lexatumumab | |||
| Imidazole Mustard | |||
| Liarozole Fumarate | |||
| Blinatumomab | |||
| Ladirubicin | |||
| Monoclonal Antibody HuHMFG1 | |||
| Ras Peptide VAL | |||
| Personalized Peptide Cancer Vaccine NEO-PV-01 | |||
| Anti-prolactin Receptor Antibody LFA102 | |||
| 2-Methoxyestrone | |||
| RNR Inhibitor COH29 | |||
| Oral Picoplatin | |||
| Clinical Trial Agent | |||
| PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901 | |||
| Bimiralisib | |||
| Sardomozide | |||
| ALK/TRK Inhibitor TSR-011 | |||
| Multi-kinase Inhibitor TPX-0022 | |||
| STAT3 Inhibitor WP1066 | |||
| eIF4E Antisense Oligonucleotide ISIS 183750 | |||
| Carboxyamidotriazole | |||
| Extended-release Onapristone | |||
| PI3K/BET Inhibitor LY294002 | |||
| Liposomal Rhenium Re 186 | |||
| Thioinosine | |||
| Timonacic | |||
| Ribosome-Inactivating Protein CY503 | |||
| Fosgemcitabine Palabenamide | |||
| Recombinant Human Plasminogen Kringle 5 Domain ABT 828 | |||
| Mcl-1 Inhibitor AZD5991 | |||
| Phospholipid Ether-drug Conjugate CLR 131 | |||
| Alemtuzumab | |||
| Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E | |||
| Sodium Butyrate | |||
| Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 | |||
| Dihydroorotate Dehydrogenase Inhibitor BAY2402234 | |||
| Lutetium Lu 177-DTPA-omburtamab | |||
| Methylmercaptopurine Riboside | |||
| Anti-CD73 Monoclonal Antibody BMS-986179 | |||
| Aglatimagene Besadenovec | |||
| Detorubicin | |||
| Anti-CEA BiTE Monoclonal Antibody AMG211 | |||
| Alestramustine | |||
| JAK2 Inhibitor AZD1480 | |||
| Y 90 Monoclonal Antibody HMFG1 | |||
| HPV E6/E7-encoding Arenavirus Vaccine HB-201 | |||
| Talaporfin Sodium | |||
| Anti-LAG3 Monoclonal Antibody MK-4280 | |||
| Leflunomide | |||
| VEGFR-2 DNA Vaccine VXM01 | |||
| Busulfan | |||
| Anti-CD37 MMAE Antibody-drug Conjugate AGS67E | |||
| pan-RAF Kinase Inhibitor TAK-580 | |||
| Azacitidine | |||
| Clodronate Disodium | |||
| Vincristine Liposomal | |||
| Neoantigen-based Melanoma-Poly-ICLC Vaccine | |||
| Enobosarm | |||
| Inotuzumab Ozogamicin | |||
| BET-bromodomain Inhibitor ODM-207 | |||
| Daunorubicin Citrate | |||
| Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302 | |||
| Fosaprepitant | |||
| Edotecarin | |||
| Fluorouracil Implant | |||
| Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa | |||
| Zinc Finger Nuclease ZFN-603 | |||
| Idarubicin Hydrochloride | |||
| Triazene Derivative TriN2755 | |||
| Alpha V Beta 8 Antagonist PF-06940434 | |||
| Niraparib Tosylate Monohydrate | |||
| Procarbazine Hydrochloride | |||
| MET Tyrosine Kinase Inhibitor EMD 1204831 | |||
| CD123-specific Targeting Module TM123 | |||
| Y 90 Monoclonal Antibody m170 | |||
| Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701 | |||
| Talmapimod | |||
| SMO Protein Inhibitor ZSP1602 | |||
| Taletrectinib | |||
| Entolimod | |||
| CD44v6-specific CAR T-cells | |||
| Monoclonal Antibody ASP1948 | |||
| Adenosine A2B Receptor Antagonist PBF-1129 | |||
| Liposomal Mitoxantrone Hydrochloride | |||
| Phenyl Acetate | |||
| Doxorubicin-loaded EGFR-targeting Nanocells | |||
| Mivavotinib | |||
| Levothyroxine Sodium | |||
| Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225 | |||
| Ethyleneimine | |||
| Threonine Tyrosine Kinase Inhibitor CFI-402257 | |||
| ROBO1-targeted BiCAR-NKT Cells | |||
| Micellar Nanoparticle-encapsulated Epirubicin | |||
| Shared Anti-Idiotype-AB-S006 | |||
| Ribociclib/Letrozole | |||
| JAK1 Inhibitor INCB052793 | |||
| Artesunate | |||
| Recombinant Interferon Alpha 2b-like Protein | |||
| Ortataxel | |||
| Indisulam | |||
| Mitomycin | |||
| Deferoxamine Mesylate | |||
| Cyclin-dependent Kinase Inhibitor PF-06873600 | |||
| Bcl-2 Inhibitor BGB-11417 | |||
| Miltefosine | |||
| Cationic Peptide Cream Cypep-1 | |||
| Allodepleted T Cell Immunotherapeutic ATIR101 | |||
| ITK Inhibitor CPI-818 | |||
| C/EBP Beta Antagonist ST101 | |||
| Anti-DLL3/CD3 BiTE Antibody AMG 757 | |||
| Namodenoson | |||
| Long Peptide Vaccine 7 | |||
| Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1 | |||
| Olaparib | |||
| Taselisib | |||
| Polidocanol | |||
| Danusertib | |||
| Polypodium leucotomos Extract | |||
| Platinum Acetylacetonate-Titanium Dioxide Nanoparticles | |||
| KRN5500 | |||
| Efatutazone Dihydrochloride | |||
| Liothyronine Sodium | |||
| Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006 | |||
| Sasanlimab | |||
| Nirogacestat | |||
| Ciltacabtagene Autoleucel | |||
| Benzaldehyde Dimethane Sulfonate | |||
| Pralsetinib | |||
| Ibrutinib | |||
| Polo-like Kinase 1 Inhibitor MK1496 | |||
| Cyclodisone | |||
| Recombinant Modified Vaccinia Ankara-5T4 Vaccine | |||
| Doxorubicin Prodrug L-377,202 | |||
| Oncolytic Newcastle Disease Virus MTH-68H | |||
| Recombinant Thyroglobulin | |||
| Oral Ixabepilone | |||
| Nitrogen Mustard Prodrug PR-104 | |||
| CXCR4 Inhibitor Q-122 | |||
| CXCR4 Antagonist BL-8040 | |||
| Patupilone | |||
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217 | |||
| Anti-Melanin Monoclonal Antibody PTI-6D2 | |||
| Leuprolide Mesylate Injectable Suspension | |||
| Fibromun | |||
| Verubulin Hydrochloride | |||
| Anti-CD30/DM1 Antibody-drug Conjugate F0002 | |||
| Antibody-Drug Conjugate DFRF4539A | |||
| iPSC-derived CD16-expressing Natural Killer Cells FT516 | |||
| 13-Deoxydoxorubicin | |||
| Lisavanbulin | |||
| TrkA Inhibitor VMD-928 | |||
| MEK Inhibitor SHR 7390 | |||
| Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207 | |||
| Sodium Selenite | |||
| Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine | |||
| Anti-CD47 Monoclonal Antibody IBI188 | |||
| Telisotuzumab Vedotin | |||
| Antrodia cinnamomea Supplement | |||
| TGFbeta Inhibitor LY3200882 | |||
| Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480 | |||
| Realgar-Indigo naturalis Formulation | |||
| Anti-B7-H4 Monoclonal Antibody FPA150 | |||
| Mifamurtide | |||
| Olivomycin | |||
| Anti-PD-1 Fusion Protein AMP-224 | |||
| Mercaptopurine | |||
| Talotrexin | |||
| SERD GDC-9545 | |||
| Gemcitabine-Phosphoramidate Hydrochloride NUC-1031 | |||
| Trabedersen | |||
| Mitotane | |||
| PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480 | |||
| Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47 | |||
| Guselkumab | |||
| Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014 | |||
| Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1 | |||
| Recombinant Platelet Factor 4 | |||
| HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001 | |||
| Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111 | |||
| Ningetinib Tosylate | |||
| MCL-1 inhibitor AMG 397 | |||
| HDAC Inhibitor CXD101 | |||
| Samotolisib | |||
| Neoantigen-based Therapeutic Cancer Vaccine GRT-C903 | |||
| Penclomedine | |||
| Altretamine | |||
| Teniposide | |||
| AKR1C3-activated Prodrug OBI-3424 | |||
| Anti-CD117 Monoclonal Antibody JSP191 | |||
| Hsp90 Inhibitor AB-010 | |||
| HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901 | |||
| Ionomycin | |||
| Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669 | |||
| Vopratelimab | |||
| Human MOAB LICO 28a32 | |||
| Rofecoxib | |||
| Anti-CD47 Monoclonal Antibody CC-90002 | |||
| Samrotamab Vedotin | |||
| Selective Glucocorticoid Receptor Antagonist CORT125281 | |||
| Liothyronine I-131 | |||
| Asparaginase Erwinia chrysanthemi | |||
| Obatoclax Mesylate | |||
| TLR8 Agonist DN1508052 | |||
| BTK Inhibitor ICP-022 | |||
| Arsenic Trioxide Capsule Formulation ORH 2014 | |||
| Streptozocin | |||
| Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement | |||
| Epratuzumab-cys-tesirine | |||
| Bisantrene | |||
| Antimetabolite FF-10502 | |||
| Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2 | |||
| Cycloleucine | |||
| Simurosertib | |||
| Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A | |||
| Hypericin | |||
| Monoclonal Antibody AK002 | |||
| Antibody-drug Conjugate ABBV-011 | |||
| Anti-c-Met Monoclonal Antibody ABT-700 | |||
| Anti-HER2 Antibody-drug Conjugate MEDI4276 | |||
| Alectinib | |||
| Anti-PD-1/Anti-CTLA4 DART Protein MGD019 | |||
| Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321 | |||
| Famitinib | |||
| Bruceanol A | |||
| Simtuzumab | |||
| Iodine I 131 Monoclonal Antibody CC49-deltaCH2 | |||
| Loncastuximab Tesirine | |||
| GI-4000 Vaccine | |||
| Duvelisib | |||
| Dihydrolenperone | |||
| Exemestane | |||
| Opucolimab | |||
| FGF/FGFR Pathway Inhibitor E7090 | |||
| Lintuzumab | |||
| HDAC Inhibitor OBP-801 | |||
| Tetradecanoylphorbol Acetate | |||
| Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1) | |||
| MNK1/2 Inhibitor ETC-1907206 | |||
| Necitumumab | |||
| Anti-MUC1 Monoclonal Antibody BTH1704 | |||
| Ganetespib | |||
| DNA Plasmid Encoding Interleukin-12 INO-9012 | |||
| Fulvestrant | |||
| Ambamustine | |||
| Liposomal MUC1/PET-lipid A Vaccine ONT-10 | |||
| SHP2 Inhibitor TNO155 | |||
| Polymer-encapsulated Luteolin Nanoparticle | |||
| Figitumumab | |||
| Vistusertib | |||
| Acalisib | |||
| Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029 | |||
| Naphthalimide Analogue UNBS5162 | |||
| Hormone Therapy | |||
| ERK1/2 Inhibitor KO-947 | |||
| Interferon Alfa-N1 | |||
| Pralatrexate | |||
| TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200 | |||
| Mirzotamab Clezutoclax | |||
| Anti-OX40 Agonist Monoclonal Antibody PF-04518600 | |||
| Dinutuximab | |||
| Mibefradil Dihydrochloride | |||
| Autologous NKG2D CAR T-cells CYAD-02 | |||
| MOF Compound RiMO-301 | |||
| Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055 | |||
| Methotrexate-E Therapeutic Implant | |||
| PI3K p110beta/delta Inhibitor KA2237 | |||
| Interleukin-2 Liposome | |||
| EGFR Mutant-specific Inhibitor CK-101 | |||
| Trastuzumab-TLR 7/8 Agonist BDC-1001 | |||
| Sepantronium Bromide | |||
| Not Otherwise Specified | |||
| Alpha V Beta 1 Inhibitor ATN-161 | |||
| Hsp90 Inhibitor PU-H71 | |||
| Bisnafide Dimesylate | |||
| Muparfostat | |||
| BiTE Antibody AMG 910 | |||
| Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo | |||
| Personalized ALL-specific Multi-HLA-binding Peptide Vaccine | |||
| PAK4 Inhibitor PF-03758309 | |||
| Protein Arginine Methyltransferase 5 Inhibitor PRT543 | |||
| Holmium Ho 166 Poly(L-Lactic Acid) Microspheres | |||
| Brostacillin Hydrochloride | |||
| Pevonedistat | |||
| Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A | |||
| Monoclonal Antibody Hu3S193 | |||
| Avdoralimab | |||
| Pharmacological Ascorbate | |||
| Tositumomab | |||
| Dacomitinib | |||
| Custirsen Sodium | |||
| Nanosomal Docetaxel Lipid Suspension | |||
| Duborimycin | |||
| Anti-FGFR4 Monoclonal Antibody U3-1784 | |||
| MDR Modulator CBT-1 | |||
| Agatolimod Sodium | |||
| PTEF-b/CDK9 Inhibitor BAY1251152 | |||
| p53 Peptide Vaccine MPS-128 | |||
| Survivin Antigen Vaccine DPX-Survivac | |||
| Warfarin Sodium | |||
| ATR Inhibitor RP-3500 | |||
| Anti-PD-1/Anti-LAG-3 DART Protein MGD013 | |||
| Anti-LAG-3/PD-L1 Bispecific Antibody FS118 | |||
| Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride | |||
| CD80-Fc Fusion Protein FPT155 | |||
| Epirubicin Hydrochloride | |||
| Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012 | |||
| Anti-CCR7 Antibody-drug Conjugate JBH492 | |||
| Tilarginine | |||
| Immunotherapy Regimen MKC-1106-MT | |||
| IDH1 Mutant Inhibitor LY3410738 | |||
| Retinyl Acetate | |||
| TGF-beta Receptor 1 Kinase Inhibitor YL-13027 | |||
| Iodine I 131 Derlotuximab Biotin | |||
| Banoxantrone | |||
| Patidegib Topical Gel | |||
| Partially Engineered T-regulatory Cell Donor Graft TRGFT-201 | |||
| Autologous Anti-CD123 CAR-T Cells | |||
| Zanubrutinib | |||
| Trastuzumab Deruxtecan | |||
| Pembrolizumab | |||
| Anti-HER3 Antibody-drug Conjugate U3 1402 | |||
| Protein Stabilized Liposomal Docetaxel Nanoparticles | |||
| Irinotecan Sucrosofate | |||
| Y 90 Monoclonal Antibody CC49 | |||
| BCG Tokyo-172 Strain Solution | |||
| BC-819 Plasmid/Polyethylenimine Complex | |||
| Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10 | |||
| CHP-NY-ESO-1 Peptide Vaccine IMF-001 | |||
| Alkotinib | |||
| MALT1 Inhibitor JNJ-67856633 | |||
| Retinoic Acid Agent Ro 16-9100 | |||
| Fas Receptor Agonist APO010 | |||
| Spiromustine | |||
| Sergiolide | |||
| Umbralisib | |||
| Monoclonal Antibody SGN-14 | |||
| CDK7 Inhibitor CT7001 | |||
| Glucarpidase | |||
| BTK Inhibitor ARQ 531 | |||
| Anti-DKK-1 Monoclonal Antibody LY2812176 | |||
| Anti-EGFR/DM1 Antibody-drug Conjugate AVID100 | |||
| Tubulin Inhibitor ALB 109564 Dihydrochloride | |||
| Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001 | |||
| Depatuxizumab Mafodotin | |||
| Anti-CD39 Monoclonal Antibody SRF617 | |||
| Cabozantinib | |||
| Oral Azacitidine | |||
| Cevipabulin | |||
| Milciclib Maleate | |||
| Anti-HER2/MMAE Antibody-drug Conjugate MRG002 | |||
| Ponatinib | |||
| Penberol | |||
| Recombinant Adenovirus-p53 SCH-58500 | |||
| Monoclonal Antibody GD2 Anti-Idiotype Vaccine | |||
| Allogeneic Anti-CD19 Universal CAR-T Cells CTA101 | |||
| Survivin Antigen | |||
| Etanercept | |||
| CDK1/2/4 Inhibitor AG-024322 | |||
| Medorubicin | |||
| Bizelesin | |||
| Autologous TCRm-expressing T-cells ET140203 | |||
| Recombinant Interleukin-2 | |||
| Poly-alendronate Dextran-Guanidine Conjugate | |||
| Androgen Receptor Antagonist BAY 1161116 | |||
| Taladegib | |||
| Anti-CD3/CD7-Ricin Toxin A Immunotoxin | |||
| Apolizumab | |||
| STAT Inhibitor OPB-111077 | |||
| Pictilisib Bismesylate | |||
| c-Met Inhibitor HS-10241 | |||
| 9H-Purine-6Thio-98D | |||
| Plamotamab | |||
| Resistant Starch | |||
| NAMPT Inhibitor OT-82 | |||
| CD4-specific Telomerase Peptide Vaccine UCPVax | |||
| Aviscumine | |||
| Fostriecin | |||
| Antineoplaston A10 | |||
| c-Met Inhibitor AMG 208 | |||
| Tavolimab | |||
| Bcl-2 Inhibitor LP-108 | |||
| Trifluridine and Tipiracil Hydrochloride | |||
| Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006 | |||
| Anti-CD33/CD3 BiTE Antibody AMG 330 | |||
| Topoisomerase-II-beta Inhibitor Racemic XK469 | |||
| Anti-ICOS Agonist Monoclonal Antibody BMS-986226 | |||
| Detirelix | |||
| Motixafortide | |||
| Tyrosine Kinase Inhibitor SU5402 | |||
| Belagenpumatucel-L | |||
| Anti-TF Monoclonal Antibody ALT-836 | |||
| Tasidotin | |||
| Palbociclib Isethionate | |||
| SERD G1T48 | |||
| Brigatinib | |||
| Leurubicin | |||
| Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962 | |||
| Glaucarubolone | |||
| Anti-CD45 Monoclonal Antibody AHN-12 | |||
| Docetaxel | |||
| Piroxantrone | |||
| Linrodostat | |||
| HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c | |||
| BP-Cx1-Platinum Complex BP-C1 | |||
| Epipropidine | |||
| Multipeptide Vaccine S-588210 | |||
| Prednisone | |||
| HDM2 Inhibitor HDM201 | |||
| Erbulozole | |||
| Trodusquemine | |||
| Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591 | |||
| Factor VIIa Inhibitor PCI-27483 | |||
| 2-Fluorofucose-containing SGN-2FF | |||
| Anti-CD20-engineered Toxin Body MT-3724 | |||
| EGFR Mutant-selective Inhibitor TQB3804 | |||
| Monoclonal Antibody CC49-delta CH2 | |||
| Monoclonal Antibody CAL | |||
| Liposomal Topotecan FF-10850 | |||
| Anti-AXL Fusion Protein AVB-S6-500 | |||
| Anti-CD47 Monoclonal Antibody SHR-1603 | |||
| Ublituximab | |||
| Adenosine A2A/A2B Receptor Antagonist AB928 | |||
| Lorlatinib | |||
| Emofolin Sodium | |||
| Plitidepsin | |||
| Methylselenocysteine | |||
| Motexafin Gadolinium | |||
| AR Antagonist BMS-641988 | |||
| Retifanlimab | |||
| Pertuzumab | |||
| Pemetrexed | |||
| MET Tyrosine Kinase Inhibitor PF-04217903 | |||
| MUC1-targeted Peptide GO-203-2C | |||
| Cytokine-based Biologic Agent IRX-2 | |||
| BCMA-CD19 Compound CAR T Cells | |||
| PI3K/mTOR Kinase Inhibitor PF-04691502 | |||
| Sacituzumab Govitecan | |||
| Anti-PD-1/VEGF Bispecific Antibody AK112 | |||
| Pegylated Liposomal Mitoxantrone Hydrochloride | |||
| Anti-PD-1 Monoclonal Antibody CS1003 | |||
| Geranylgeranyltransferase I Inhibitor | |||
| Imidazole-Pyrazole | |||
| Adenosine A2A Receptor Antagonist NIR178 | |||
| Interferon Gamma-1b | |||
| Sotorasib | |||
| Oligonucleotide SPC2996 | |||
| TIGIT Inhibitor M6223 | |||
| Carubicin Hydrochloride | |||
| Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A | |||
| Anti-CD40 Agonist Monoclonal Antibody CDX-1140 | |||
| p97 Inhibitor CB-5339 | |||
| Limonene, (+/-)- | |||
| Recombinant Interferon Gamma | |||
| CYL-02 Plasmid DNA | |||
| Anti-TIGIT Monoclonal Antibody BGB-A1217 | |||
| Rucaparib Phosphate | |||
| Teglarinad Chloride | |||
| Anti-HA Epitope Monoclonal Antibody MEDI8852 | |||
| Annamycin Liposomal | |||
| Pomalidomide | |||
| Burixafor Hydrobromide | |||
| Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011 | |||
| Anti-PD-L1 Monoclonal Antibody ZKAB001 | |||
| Ziv-Aflibercept | |||
| Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F | |||
| Anti-CD30 Monoclonal Antibody MDX-1401 | |||
| Degarelix Acetate | |||
| Placebo | |||
| Anti-Globo H Monoclonal Antibody OBI-888 | |||
| ATM Kinase Inhibitor AZD0156 | |||
| Cenersen | |||
| Liposomal Eribulin Mesylate | |||
| PI3K/mTOR Kinase Inhibitor DS-7423 | |||
| Spanlecortemlocel | |||
| Src Kinase Inhibitor KX2-391 | |||
| Anti-PD-L1 Monoclonal Antibody TG-1501 | |||
| Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005 | |||
| Beta-elemene | |||
| Erythrocyte-encapsulated L-asparaginase Suspension | |||
| Lutetium Lu 177 Lilotomab-satetraxetan | |||
| Ladiratuzumab Vedotin | |||
| Anti-GARP Monoclonal Antibody ABBV-151 | |||
| Maytansine | |||
| Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244 | |||
| Dynemicin | |||
| Mofarotene | |||
| Hydroxyurea | |||
| Hsp90 Inhibitor TQB3474 | |||
| Canfosfamide | |||
| H-ras Antisense Oligodeoxynucleotide ISIS 2503 | |||
| Tilsotolimod Sodium | |||
| BET Inhibitor INCB057643 | |||
| Tesevatinib | |||
| Dicycloplatin | |||
| KRAS G12C Inhibitor LY3499446 | |||
| WT1 Peptide Vaccine WT2725 | |||
| Lodapolimab | |||
| Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191 | |||
| Dynemicin A | |||
| Pegylated Interferon Alfa | |||
| Anti-IL-1 alpha Monoclonal Antibody MABp1 | |||
| Silmitasertib Sodium | |||
| Cytarabine-asparagine Prodrug BST-236 | |||
| Seviteronel | |||
| Bisnafide | |||
| FGFR4 Inhibitor H3B-6527 | |||
| Anti-PD1/CTLA4 Bispecific Antibody XmAb20717 | |||
| Monocarboxylate Transporter 1 Inhibitor AZD3965 | |||
| Anti-OX40 Monoclonal Antibody IBI101 | |||
| Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999 | |||
| Benzoylphenylurea | |||
| Pioglitazone Hydrochloride | |||
| Bemarituzumab | |||
| MUC-1/WT1 Peptide-primed Autologous Dendritic Cells | |||
| Ilorasertib | |||
| 7-Ethyl-10-Hydroxycamptothecin | |||
| Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128 | |||
| Autologous AXL-targeted CAR T-cells CCT301-38 | |||
| Anti-ErbB3 Antibody ISU104 | |||
| Other | |||
| PI3K Inhibitor GDC-0084 | |||
| Girentuximab | |||
| EGFR Antagonist Hemay022 | |||
| Halofuginone | |||
| Liarozole | |||
| Actinomycin C3 | |||
| KRASG12C Inhibitor JNJ-74699157 | |||
| MET Tyrosine Kinase Inhibitor SAR125844 | |||
| 8-Azaguanine | |||
| Photodynamic Compound TLD-1433 | |||
| Idelalisib | |||
| CDK2/4/6/FLT3 Inhibitor FN-1501 | |||
| Morinda Citrifolia Fruit Extract | |||
| Ondansetron Hydrochloride | |||
| CEBPA-targeting saRNA MTL-CEBPA Liposome | |||
| Tisotumab Vedotin | |||
| Anti-CD123 Monoclonal Antibody CSL360 | |||
| Elacestrant | |||
| Methanol Extraction Residue of BCG | |||
| Lavendustin A | |||
| Demecolcine | |||
| Acridine | |||
| Picibanil | |||
| Indocyanine Green-labeled Polymeric Micelles ONM-100 | |||
| Halichondrin B | |||
| Avelumab | |||
| Phosphoramide Mustard | |||
| Carmustine | |||
| Anti-CD38 Monoclonal Antibody MOR03087 | |||
| Mipsagargin | |||
| Pentostatin | |||
| EZH2 Inhibitor SHR2554 | |||
| Licartin | |||
| HDAC8 Inhibitor NBM-BMX | |||
| CDK Inhibitor AT7519 | |||
| CAB-ROR2-ADC BA3021 | |||
| Interleukin-15 Agonist Fusion Protein SHR1501 | |||
| Redaporfin | |||
| Recombinant Tyrosinase-Related Protein-2 | |||
| Zalifrelimab | |||
| Trastuzumab Monomethyl Auristatin F | |||
| Zandelisib | |||
| Idecabtagene Vicleucel | |||
| Anti-PD-1/TIM-3 Bispecific Antibody RO7121661 | |||
| Demplatin Pegraglumer | |||
| hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301 | |||
| Hsp90 Inhibitor DS-2248 | |||
| CTLA-4-directed Probody BMS-986249 | |||
| Cimetidine | |||
| NY-ESO-1/GLA-SE Vaccine ID-G305 | |||
| Pirarubicin | |||
| Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949 | |||
| Romidepsin | |||
| Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01 | |||
| Anti-PD-1 Monoclonal Antibody JTX-4014 | |||
| Ancitabine | |||
| KRAS G12C Inhibitor GDC-6036 | |||
| Imipramine Blue | |||
| ATR Kinase Inhibitor M1774 | |||
| Pegylated Liposomal Irinotecan | |||
| Siplizumab | |||
| Liarozole Hydrochloride | |||
| Anti-CD19 Monoclonal Antibody XmAb5574 | |||
| Nazartinib | |||
| Laniquidar | |||
| Anti-LAG3 Monoclonal Antibody BI 754111 | |||
| Mitomycin A | |||
| Crenolanib | |||
| Gemcitabine Elaidate | |||
| Ruxotemitide | |||
| F16-IL2 Fusion Protein | |||
| Anti-mesothelin/MMAE Antibody-drug Conjugate RC88 | |||
| Mutant-selective EGFR Inhibitor PF-06459988 | |||
| Pelabresib | |||
| Gallium-based Bone Resorption Inhibitor AP-002 | |||
| Amolimogene Bepiplasmid | |||
| Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621 | |||
| Etirinotecan Pegol | |||
| Elbasvir/Grazoprevir | |||
| Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143 | |||
| Laromustine | |||
| C-VISA BikDD:Liposome | |||
| Clodronic Acid | |||
| Mivobulin | |||
| Anti-LGR5 Monoclonal Antibody BNC101 | |||
| FAK Inhibitor VS-4718 | |||
| Autologous Anti-CD19 TAC-T cells TAC01-CD19 | |||
| Cordycepin | |||
| Anti-CD20 Monoclonal Antibody PRO131921 | |||
| HER2 Inhibitor TAS0728 | |||
| Colloidal Gold-Bound Tumor Necrosis Factor | |||
| RhoC Peptide Vaccine RV001V | |||
| VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 | |||
| Methylprednisolone Sodium Succinate | |||
| STAT3 Inhibitor TTI-101 | |||
| Infliximab | |||
| NG-nitro-L-arginine | |||
| EGFR Mutant-specific Inhibitor D-0316 | |||
| Iodine I 124 Monoclonal Antibody M5A | |||
| Onvatilimab | |||
| Anti-BTN3A Agonistic Monoclonal Antibody ICT01 | |||
| Human Papillomavirus 16 E7 Peptide/Padre 965.10 | |||
| Cancer Peptide Vaccine S-588410 | |||
| Y 90 Monoclonal Antibody Lym-1 | |||
| Antineoplastic Vaccine GV-1301 | |||
| TAM/c-Met Inhibitor RXDX-106 | |||
| Fenretinide Lipid Matrix | |||
| Veltuzumab | |||
| TGFa-PE38 Immunotoxin | |||
| pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0 | |||
| Rucaparib Camsylate | |||
| CSF1R Inhibitor ABSK021 | |||
| Ibritumomab Tiuxetan | |||
| Inproquone | |||
| STAT3 Inhibitor OPB-51602 | |||
| Icotinib Hydrochloride | |||
| Dexrazoxane | |||
| Enasidenib Mesylate | |||
| AKT Inhibitor ARQ 092 | |||
| Recombinant Oncolytic Poliovirus PVS-RIPO | |||
| Anti-KIR Monoclonal Antibody IPH 2101 | |||
| Lovastatin | |||
| Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19 | |||
| Anti-AGS-8 Monoclonal Antibody AGS-8M4 | |||
| Anti-ROR1 ADC VLS-101 | |||
| Zibotentan | |||
| Tetanus Toxoid Vaccine | |||
| Ulinastatin | |||
| Anti-CD37 Antibody-Drug Conjugate IMGN529 | |||
| EGFR/HER2 Kinase Inhibitor TAK-285 | |||
| HPV E6/E7 DNA Vaccine GX-188E | |||
| 11D10 AluGel Anti-Idiotype Monoclonal Antibody | |||
| Synthetic Plumbagin PCUR-101 | |||
| Apilimod Dimesylate Capsule | |||
| FGFR4 Inhibitor FGF401 | |||
| Telapristone Acetate | |||
| Src/Abl Kinase Inhibitor AZD0424 | |||
| Monoclonal Antibody HuAFP31 | |||
| Ciforadenant | |||
| BRAFV600/PI3K Inhibitor ASN003 | |||
| Acitretin | |||
| Nolatrexed Dihydrochloride | |||
| Liver X Receptor beta Agonist RGX-104 | |||
| Otlertuzumab | |||
| Eftozanermin Alfa | |||
| Tazemetostat | |||
| Ianalumab | |||
| ALK/c-Met Inhibitor TQ-B3139 | |||
| Dalantercept | |||
| Dovitinib | |||
| MEK-1/MEKK-1 Inhibitor E6201 | |||
| Cobomarsen | |||
| Immunotherapeutic GSK1572932A | |||
| Prexigebersen | |||
| FGFR Inhibitor AZD4547 | |||
| Kanglaite | |||
| Nintedanib | |||
| Anti-TAG-72 Monoclonal Antibody scFV CC-49/218 | |||
| Cryptophycin | |||
| Quarfloxin | |||
| Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702 | |||
| Anti-CD19/CD3 BiTE Antibody AMG 562 | |||
| Alofanib | |||
| siG12D LODER | |||
| Anti-PGF Monoclonal Antibody RO5323441 | |||
| Anti-EGFR Monoclonal Antibody RO5083945 | |||
| Ramucirumab | |||
| RET/SRC Inhibitor TPX-0046 | |||
| Tesetaxel | |||
| Thyroid Extract | |||
| P-cadherin Inhibitor PCA062 | |||
| MEK Inhibitor TAK-733 | |||
| CDK4/6 Inhibitor | |||
| CDK Inhibitor R547 | |||
| Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine | |||
| Capivasertib | |||
| Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F | |||
| Allogeneic Natural Killer Cell Line NK-92 | |||
| Ovapuldencel-T | |||
| Rosopatamab | |||
| Carmofur | |||
| Telatinib Mesylate | |||
| Letolizumab | |||
| Puromycin Hydrochloride | |||
| Lutetium Lu-177 Capromab | |||
| mTOR Inhibitor GDC-0349 | |||
| Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013 | |||
| MetAP2 Inhibitor SDX-7320 | |||
| Autologous Dendritic Cell Vaccine ACT2001 | |||
| Larotinib Mesylate | |||
| Glioblastoma Multiforme Multipeptide Vaccine IMA950 | |||
| Sustained-release Lipid Inhaled Cisplatin | |||
| Mechlorethamine Hydrochloride | |||
| Yttrium Y 90-DOTA-Biotin | |||
| Anti-CEACAM6 Antibody BAY1834942 | |||
| Vadacabtagene Leraleucel | |||
| Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918 | |||
| PRMT5 Inhibitor JNJ-64619178 | |||
| Avadomide Hydrochloride | |||
| Galectin-1 Inhibitor OTX008 | |||
| Pegfilgrastim | |||
| BTK inhibitor TG-1701 | |||
| Anti-sCLU Monoclonal Antibody AB-16B5 | |||
| Glumetinib | |||
| Oncolytic Adenovirus ORCA-010 | |||
| Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME | |||
| Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells | |||
| LSD1 Inhibitor GSK2879552 | |||
| Medroxyprogesterone | |||
| STING Agonist IMSA101 | |||
| Smoothened Antagonist LDE225 Topical | |||
| Dociparstat sodium | |||
| Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR | |||
| Hexylresorcinol | |||
| mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902 | |||
| Anti-TROP2 Antibody-drug Conjugate BAT8003 | |||
| Aerosol Gemcitabine | |||
| Lilotomab | |||
| Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10 | |||
| HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C | |||
| Cationic Liposome-Encapsulated Paclitaxel | |||
| EGFR/TGFb Fusion Monoclonal Antibody BCA101 | |||
| Brostallicin | |||
| Copper Cu 64-ATSM | |||
| 2-Fluoroadenine | |||
| Anti-DR5 Agonistic Antibody DS-8273a | |||
| Anti-MUC17/CD3 BiTE Antibody AMG 199 | |||
| Alpha-Gal AGI-134 | |||
| Iodine I-131 | |||
| Mps1 Inhibitor BAY 1217389 | |||
| Allogeneic Anti-CD19 CAR T-cells ALLO-501A | |||
| Paxalisib | |||
| Docetaxel-PNP | |||
| Tipifarnib | |||
| IGF-1R Inhibitor PL225B | |||
| Vecabrutinib | |||
| Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3 | |||
| CDC7 Kinase Inhibitor BMS-863233 | |||
| Apoptosis Inducer BZL101 | |||
| Etoposide Toniribate | |||
| Fenretinide | |||
| MEK Inhibitor HL-085 | |||
| Zoledronic Acid | |||
| Isobrucein B | |||
| Fotretamine | |||
| Tigatuzumab | |||
| Abarelix | |||
| Anti-PD-1 Monoclonal Antibody BAT1306 | |||
| Sustained-release Mitomycin C Hydrogel Formulation UGN-101 | |||
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401 | |||
| Volasertib | |||
| Drozitumab | |||
| Leucovorin | |||
| Anti-PSMA Monoclonal Antibody MDX1201-A488 | |||
| Temozolomide | |||
| Pictilisib | |||
| Immediate-release Tablet Afuresertib | |||
| Polyandrol | |||
| 7-Hydroxystaurosporine | |||
| Cemadotin Hydrochloride | |||
| Vorinostat | |||
| Elliptinium | |||
| Forodesine Hydrochloride | |||
| Recombinant Human Apolipoprotein(a) Kringle V MG1102 | |||
| Oligo-fucoidan | |||
| Calcium Release-activated Channels Inhibitor RP4010 | |||
| Androgen Receptor Antisense Oligonucleotide EZN-4176 | |||
| Brilanestrant | |||
| Monoclonal Antibody Me1-14 F(ab')2 | |||
| Anti-HLA-DR Monoclonal Antibody IMMU-114 | |||
| Anti-PD-L1 Monoclonal Antibody RC98 | |||
| Hydroxyprogesterone Caproate | |||
| Etoposide | |||
| Evofosfamide | |||
| Betaglucin Gel | |||
| Radotinib Hydrochloride | |||
| Azathioprine | |||
| Anti-FLT3 Antibody-drug Conjugate AGS62P1 | |||
| OxPhos Inhibitor VLX600 | |||
| SHP2 Inhibitor RLY-1971 | |||
| Tirabrutinib | |||
| Trametinib Dimethyl Sulfoxide | |||
| Irosustat | |||
| Anti-NRP1 Antibody ASP1948 | |||
| Ropidoxuridine | |||
| Fadrozole Hydrochloride | |||
| Anti-GITR Agonistic Monoclonal Antibody BMS-986156 | |||
| Amustaline | |||
| Bryostatin 1 | |||
| Lutetium Lu 177 Monoclonal Antibody J591 | |||
| VEGF/HGF-targeting DARPin MP0250 | |||
| Xiliertinib | |||
| Liposomal Vinorelbine Tartrate | |||
| Bcl-2 Inhibitor BCL201 | |||
| Mitolactol | |||
| Ispinesib | |||
| Transdermal 4-Hydroxytestosterone | |||
| Calcium Release-activated Channel Inhibitor CM4620 | |||
| MEK/Aurora Kinase Inhibitor BI 847325 | |||
| Uzansertib | |||
| Cabozantinib S-malate | |||
| Pemigatinib | |||
| Yttrium Y 90-Edotreotide | |||
| Trans Sodium Crocetinate | |||
| Norgestrel | |||
| Alpha Galactosylceramide | |||
| Tegafur-gimeracil-oteracil Potassium | |||
| Monoclonal Antibody HuPAM4 | |||
| Pyrotinib | |||
| Cyclin-dependent Kinase 8/19 Inhibitor BCD 115 | |||
| Cobimetinib | |||
| Masitinib Mesylate | |||
| Pipendoxifene | |||
| Anti-CD19 Monoclonal Antibody DI-B4 | |||
| Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217 | |||
| VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820 | |||
| Acodazole Hydrochloride | |||
| Oral Hsp90 Inhibitor IPI-493 | |||
| CDK4 Inhibitor P1446A-05 | |||
| EGFR Mutant-specific Inhibitor BPI-7711 | |||
| CD44 Targeted Agent SPL-108 | |||
| Riviciclib | |||
| Anti-CD33/CD3 Bispecific Antibody JNJ-67571244 | |||
| Landogrozumab | |||
| Anti-PD-1 Monoclonal Antibody SCT-I10A | |||
| Upifitamab | |||
| Docetaxel Nanoparticle CPC634 | |||
| Citatuzumab Bogatox | |||
| Monoclonal Antibody 4B5 Anti-Idiotype Vaccine | |||
| Proapoptotic Sulindac Analog CP-461 | |||
| PD-L1 Inhibitor INCB086550 | |||
| Camptothecin | |||
| Lutetium Lu 177 DOTA-Tetulomab | |||
| MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP | |||
| Uracil Ointment | |||
| HER2-targeted DARPin MP0274 | |||
| Brivudine | |||
| Nanafrocin | |||
| Foretinib | |||
| Anti-PD-1 Checkpoint Inhibitor PF-06801591 | |||
| Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008 | |||
| Chlorodihydropyrimidine | |||
| FPV-Brachyury-TRICOM Vaccine | |||
| Monoclonal Antibody muJ591 | |||
| MET x MET Bispecific Antibody REGN5093 | |||
| SR-T100 Gel | |||
| Pamrevlumab | |||
| Talabostat Mesylate | |||
| JAK2 Inhibitor XL019 | |||
| Navitoclax | |||
| Aurora A Kinase Inhibitor LY3295668 Erbumine | |||
| Docetaxel Anhydrous | |||
| Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1 | |||
| Anti-IRF4 Antisense Oligonucleotide ION251 | |||
| Terameprocol | |||
| Synthetic Alkaloid PM00104 | |||
| Cord Blood Derived CAR T-Cells | |||
| Rebeccamycin | |||
| Tiazofurin | |||
| Phosphatidylcholine-Bound Silybin | |||
| HLA-A*2402-Restricted Multipeptide Vaccine S-488410 | |||
| Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318 | |||
| Etoricoxib | |||
| Mannosulfan | |||
| Topical Fluorouracil | |||
| Atrasentan Hydrochloride | |||
| Bispecific Antibody MDX447 | |||
| SLC6A8 Inhibitor RGX-202 | |||
| Botanical Agent BEL-X-HG | |||
| Anti-CSF1R Monoclonal Antibody IMC-CS4 | |||
| SHP-1 Agonist SC-43 | |||
| alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801 | |||
| Splicing Inhibitor H3B-8800 | |||
| PSMA-targeted Tubulysin B-containing Conjugate EC1169 | |||
| Apricoxib | |||
| Polyvalent Melanoma Vaccine | |||
| EZH1/2 Inhibitor DS-3201 | |||
| Bi-functional Alkylating Agent VAL-083 | |||
| Atorvastatin Sodium | |||
| CDK4/6 Inhibitor G1T38 | |||
| PI3K Inhibitor BGT226 | |||
| Cemadotin | |||
| Beta Alethine | |||
| HER2 Inhibitor CP-724,714 | |||
| Anti-CD157 Monoclonal Antibody MEN1112 | |||
| Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414 | |||
| Ets-family Transcription Factor Inhibitor TK216 | |||
| Anti-CTLA-4 Monoclonal Antibody ADU-1604 | |||
| Methoxyamine | |||
| Amsacrine Lactate | |||
| Arfolitixorin | |||
| FGFR4 Inhibitor ICP-105 | |||
| Iboctadekin | |||
| CT2584 HMS | |||
| Lentinan | |||
| Calcium Saccharate | |||
| Cactinomycin | |||
| Simmitinib | |||
| Abiraterone | |||
| Anti-ICOS Monoclonal Antibody MEDI-570 | |||
| EBNA-1 inhibitor VK-2019 | |||
| Beta-Glucan MM-10-001 | |||
| Robatumumab | |||
| Synthetic Long E6/E7 Peptides Vaccine HPV-01 | |||
| Anti-EGFRvIII Immunotoxin MR1-1 | |||
| Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine | |||
| Antibody-drug Conjugate PF-06647263 | |||
| Piposulfan | |||
| Ulixertinib | |||
| TORC1/2 Kinase Inhibitor DS-3078a | |||
| Quisinostat | |||
| Sulforaphane | |||
| Calaspargase Pegol-mknl | |||
| mTOR1/2 Kinase Inhibitor ME-344 | |||
| mRNA-derived Lung Cancer Vaccine BI 1361849 | |||
| Yttrium Y 90 Monoclonal Antibody MN-14 | |||
| Mutant IDH1 Inhibitor DS-1001 | |||
| IDH1R132H-Specific Peptide Vaccine PEPIDH1M | |||
| Estramustine Phosphate Sodium | |||
| Ras Peptide ASP | |||
| Epothilone Analog UTD1 | |||
| ALK-2 Inhibitor TP-0184 | |||
| Sapacitabine | |||
| Tributyrin | |||
| Testosterone Enanthate | |||
| Fenretinide Phospholipid Suspension ST-001 | |||
| Roducitabine | |||
| Recombinant Human Papillomavirus Nonavalent Vaccine | |||
| Monoclonal Antibody AbGn-7 | |||
| Vandortuzumab Vedotin | |||
| Cinrebafusp Alfa | |||
| Alvocidib | |||
| Aprinocarsen | |||
| Pacmilimab | |||
| Anti-human GITR Monoclonal Antibody AMG 228 | |||
| Cryptophycin 52 | |||
| Peginterferon Alfa-2b | |||
| Anti-EGFR Monoclonal Antibody SCT200 | |||
| Rogaratinib | |||
| Recombinant Bispecific Single-Chain Antibody rM28 | |||
| Anti-EphA2 Monoclonal Antibody DS-8895a | |||
| Indole-3-Carbinol | |||
| Bushen-Jianpi Decoction | |||
| Selicrelumab | |||
| Autologous CD19/PD-1 Bispecific CAR-T Cells | |||
| Urabrelimab | |||
| Cobolimab | |||
| Anti-C-met Monoclonal Antibody SAIT301 | |||
| Parsaclisib Hydrochloride | |||
| Semaxanib | |||
| Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A | |||
| Erlotinib Hydrochloride | |||
| CD40 Agonist Monoclonal Antibody CP-870,893 | |||
| Selitrectinib | |||
| Elliptinium Acetate | |||
| MELK Inhibitor OTS167 | |||
| Bispecific Antibody GS-1423 | |||
| Cofetuzumab Pelidotin | |||
| Sabatolimab | |||
| Pan-AKT Inhibitor ARQ751 | |||
| Sintilimab | |||
| Crenolanib Besylate | |||
| PSMA-targeted Docetaxel Nanoparticles BIND-014 | |||
| Inosine Monophosphate Dehydrogenase Inhibitor AVN944 | |||
| Simotaxel | |||
| Xevinapant | |||
| Pan-TRK Inhibitor ONO-7579 | |||
| Attenuated Measles Virus Encoding SCD Transgene TMV-018 | |||
| Orvacabtagene Autoleucel | |||
| Nilotinib Hydrochloride Monohydrate | |||
| Calicheamicin Gamma 1I | |||
| Vintafolide | |||
| PI3K-delta Inhibitor YY-20394 | |||
| KRAS G12C Inhibitor MRTX849 | |||
| Recombinant Human Papillomavirus Bivalent Vaccine | |||
| Anti-OX40 Monoclonal Antibody GSK3174998 | |||
| PI3K Inhibitor ZSTK474 | |||
| Super Enhancer Inhibitor GZ17-6.02 | |||
| Afimoxifene | |||
| CBP/beta-catenin Antagonist PRI-724 | |||
| Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102 | |||
| Bactobolin | |||
| Liposomal Bcl-2 Antisense Oligonucleotide BP1002 | |||
| Diazepinomicin | |||
| Bispecific Antibody AGEN1223 | |||
| Varlitinib | |||
| Epacadostat | |||
| Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100 | |||
| Pan-RAF Inhibitor LY3009120 | |||
| Clioquinol | |||
| Doxazosin | |||
| Checkpoint Kinase Inhibitor AZD7762 | |||
| Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a | |||
| EGFR Antisense DNA BB-401 | |||
| Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody | |||
| Mps1 Inhibitor BOS172722 | |||
| Vinzolidine | |||
| Topoisomerase I Inhibitor LMP776 | |||
| Dendritic Cell-Autologous Lung Tumor Vaccine | |||
| Mivobulin Isethionate | |||
| Idasanutlin | |||
| Enzastaurin Hydrochloride | |||
| Garlic | |||
| ncmtRNA Oligonucleotide Andes-1537 | |||
| Cetuximab-IR700 Conjugate RM-1929 | |||
| Hypoxia-activated Prodrug TH-4000 | |||
| Taltobulin | |||
| Teclistamab | |||
| Glofitamab | |||
| Zirconium Zr 89 Panitumumab | |||
| Denibulin | |||
| Therapeutic Liver Cancer Peptide Vaccine IMA970A | |||
| I 131 Antiferritin Immunoglobulin | |||
| Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19 | |||
| Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141 | |||
| Fisogatinib | |||
| Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells | |||
| Gutolactone | |||
| Vatalanib Succinate | |||
| Goserelin Acetate Extended-release Microspheres LY01005 | |||
| Anti-PD-1 Monoclonal Antibody BI 754091 | |||
| MEK Inhibitor GDC-0623 | |||
| Samuraciclib | |||
| c-raf Antisense Oligonucleotide ISIS 5132 | |||
| Vinorelbine Tartrate Oral | |||
| Monalizumab | |||
| Angiogenesis/Heparanase Inhibitor PG545 | |||
| Synchrovax SEM Plasmid DNA Vaccine | |||
| Anti-CD19 Monoclonal Antibody MEDI-551 | |||
| Agerafenib | |||
| Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087 | |||
| Anti-FGFR2 Antibody BAY1179470 | |||
| Mirabegron | |||
| Padeliporfin | |||
| Bexarotene | |||
| Belzutifan | |||
| Tariquidar | |||
| Nanatinostat | |||
| Antibody-drug Conjugate ADC XMT-1536 | |||
| Anti-CD20/CD3 Monoclonal Antibody REGN1979 | |||
| Pacritinib | |||
| Doxorubicin | |||
| Ruxolitinib | |||
| Razoxane | |||
| Poly-gamma Glutamic Acid | |||
| Ceramide Nanoliposome | |||
| Elinafide | |||
| Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells | |||
| EGFR/HER1/HER2 Inhibitor PKI166 | |||
| Extended Release Metformin Hydrochloride | |||
| Ontuxizumab | |||
| Pazopanib | |||
| Losoxantrone Hydrochloride | |||
| Anti-CD70 Monoclonal Antibody MDX-1411 | |||
| Anti-EGFR/c-Met Bispecific Antibody EMB-01 | |||
| Mobocertinib | |||
| Recombinant Interleukin-6 | |||
| Triethylenemelamine | |||
| Individualized MVA-based Vaccine TG4050 | |||
| Ginsenoside Rg3 Capsule | |||
| Uprosertib | |||
| Ritrosulfan | |||
| Anti-PD1 Monoclonal Antibody AGEN2034 | |||
| TLR Agonist BDB001 | |||
| Recombinant Human Papillomavirus 11-valent Vaccine | |||
| Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372 | |||
| Taxol Analogue SID 530 | |||
| Capecitabine | |||
| Anti-LAG-3 Monoclonal Antibody LAG525 | |||
| Captopril | |||
| Anti-OX40 Agonist Monoclonal Antibody BGB-A445 | |||
| Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172 | |||
| Dactolisib | |||
| Immunomodulatory Oligonucleotide HYB2055 | |||
| Adavosertib | |||
| Tallimustine | |||
| FLT3/CDK4/6 Inhibitor FLX925 | |||
| Paricalcitol | |||
| Ioflubenzamide I-131 | |||
| Isocoumarin NM-3 | |||
| CCR2/CCR5 Antagonist BMS-813160 | |||
| Huaier Extract Granule | |||
| Notch Signaling Inhibitor PF-06650808 | |||
| PV-10 | |||
| Multikinase Inhibitor AT9283 | |||
| Iodine I 131 TM-601 | |||
| Anti-CD25-PBD Antibody-drug Conjugate ADCT-301 | |||
| Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101 | |||
| Siltuximab | |||
| Glycooptimized Trastuzumab-GEX | |||
| Giredestrant | |||
| Reparixin | |||
| Anti-LILRB4 Monoclonal Antibody IO-202 | |||
| Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704 | |||
| Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP | |||
| Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP | |||
| Carmustine in Ethanol | |||
| Anti-TIM-3 Monoclonal Antibody Sym023 | |||
| Therapeutic Angiotensin-(1-7) | |||
| Angiogenesis Inhibitor GT-111 | |||
| Hycanthone | |||
| Multikinase Inhibitor AEE788 | |||
| Anti-EGP-2 Immunotoxin MOC31-PE | |||
| Melanoma TRP2 CTL Epitope Vaccine SCIB1 | |||
| Autologous Anti-PSMA CAR-T Cells P-PSMA-101 | |||
| Dioscorea nipponica Makino Extract DNE3 | |||
| Eltanexor | |||
| Zanidatamab | |||
| Tanespimycin | |||
| Tosedostat | |||
| Tremelimumab | |||
| Guanabenz Acetate | |||
| Hsp90 Inhibitor Debio 0932 | |||
| Deferoxamine | |||
| Berubicin Hydrochloride | |||
| Labetuzumab Govitecan | |||
| PI3K-delta Inhibitor SHC014748M | |||
| Tarextumab | |||
| Bardoxolone | |||
| Tepoditamab | |||
| L-methylfolate | |||
| Anti-ErbB3 Monoclonal Antibody REGN1400 | |||
| Docetaxel Formulation CKD-810 | |||
| Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A | |||
| Giloralimab | |||
| Sobuzoxane | |||
| Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX | |||
| Menogaril | |||
| Bruceanol C | |||
| Enzalutamide | |||
| Dual Variable Domain Immunoglobulin ABT-165 | |||
| Rilimogene Galvacirepvec | |||
| Cerdulatinib | |||
| Anti-TIM3 Monoclonal Antibody LY3321367 | |||
| Motolimod | |||
| Anti-IGF-1R Monoclonal Antibody AVE1642 | |||
| Onalespib Lactate | |||
| Gossypol Acetic Acid | |||
| Bleomycin B2 | |||
| Anti-CD33/CD3 BiTE Antibody AMG 673 | |||
| Tesidolumab | |||
| Acolbifene Hydrochloride | |||
| Ubenimex | |||
| Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110 | |||
| Estrogen Receptor Agonist GTx-758 | |||
| Siremadlin | |||
| Gamma-delta Tocotrienol | |||
| Estrogens, Conjugated | |||
| HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202 | |||
| Halofuginone Hydrobromide | |||
| ALK/FAK/Pyk2 Inhibitor CT-707 | |||
| Anti-CA6-DM4 Immunoconjugate SAR566658 | |||
| Silatecan AR-67 | |||
| Mitoguazone Dihydrochloride | |||
| Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957 | |||
| Perflenapent Emulsion | |||
| STING Agonist GSK3745417 | |||
| BRD4 Inhibitor PLX2853 | |||
| Transdermal 17beta-Estradiol Gel BHR-200 | |||
| Pan-AKT Kinase Inhibitor GSK690693 | |||
| DPX-E7 HPV Vaccine | |||
| Ricolinostat | |||
| Defactinib Hydrochloride | |||
| Isotretinoin | |||
| Poziotinib | |||
| Nelarabine | |||
| Paclitaxel | |||
| Triptorelin | |||
| Anti-HER2 Monoclonal Antibody HLX22 | |||
| Rhenium Re-188 Etidronate | |||
| Prednisolone Sodium Phosphate | |||
| Futuximab/Modotuximab Mixture | |||
| Aminopterin Sodium | |||
| Aprutumab Ixadotin | |||
| Bruceanol F | |||
| BMS-214662 | |||
| Chk1 Inhibitor GDC-0575 | |||
| STAT3 Inhibitor OPB-31121 | |||
| Bintrafusp Alfa | |||
| IDO1 Inhibitor PF-06840003 | |||
| CXCR1/2 Inhibitor SX-682 | |||
| Topoisomerase-1 Inhibitor LMP744 | |||
| Tauromustine | |||
| Brentuximab | |||
| Bushen Culuan Decoction | |||
| Bromebric Acid | |||
| Coltuximab Ravtansine | |||
| ERK1/2 Inhibitor ASN007 | |||
| 3'-C-ethynylcytidine | |||
| Lerociclib | |||
| Bruceanol B | |||
| Anti-TIM-3 Monoclonal Antibody TSR-022 | |||
| Phenethyl Isothiocyanate | |||
| Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547 | |||
| mRNA-derived Prostate Cancer Vaccine CV9104 | |||
| PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170 | |||
| Galunisertib | |||
| Antisense Oligonucleotide QR-313 | |||
| Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318 | |||
| Anti-PD-1 Monoclonal Antibody Sym021 | |||
| Sivifene | |||
| Anti-hepcidin Monoclonal Antibody LY2787106 | |||
| Anti-IL-15 Monoclonal Antibody AMG 714 | |||
| ATR Kinase Inhibitor BAY1895344 | |||
| Theramide | |||
| Multi-epitope HER2 Peptide Vaccine H2NVAC | |||
| EGFR Inhibitor PD-168393 | |||
| ERK Inhibitor LTT462 | |||
| Lobaplatin | |||
| Filanesib | |||
| DACH-Platin Micelle NC-4016 | |||
| IDO1 Inhibitor KHK2455 | |||
| JAK2/Src Inhibitor NS-018 | |||
| MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201 | |||
| Esperamicin A1 | |||
| Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100 | |||
| Anti-BCMA/CD3 BiTE Antibody AMG 420 | |||
| Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002 | |||
| Carboxyamidotriazole Orotate | |||
| Anti-CD40 Monoclonal Antibody Chi Lob 7/4 | |||
| Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet | |||
| Paclitaxel Polymeric Micelle Formulation NANT-008 | |||
| Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex | |||
| Microbiome-derived Peptide Vaccine EO2401 | |||
| Peretinoin | |||
| Docetaxel Lipid Microspheres | |||
| Tertomotide | |||
| c-Kit Inhibitor PLX9486 | |||
| Acivicin | |||
| Black Raspberry Nectar | |||
| Trioxifene | |||
| SMAC Mimetic BI 891065 | |||
| Apatorsen | |||
| DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine | |||
| Vandetanib-eluting Radiopaque Bead BTG-002814 | |||
| MYC-targeting siRNA DCR-MYC | |||
| Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01 | |||
| Anti-VEGF Monoclonal Antibody hPV19 | |||
| CDK4/6 Inhibitor TQB3616 | |||
| Albumin-binding Cisplatin Prodrug BTP-114 | |||
| Firtecan Pegol | |||
| Anti-TIM-3 Monoclonal Antibody BGB-A425 | |||
| Monoclonal Antibody 3H1 Anti-Idiotype Vaccine | |||
| Resiquimod | |||
| Yang Yin Fu Zheng | |||
| T900607 | |||
| Retelliptine | |||
| Anti-MUC16/CD3 BiTE Antibody REGN4018 | |||
| Recombinant Human Adenovirus Type 5 H101 | |||
| Atorvastatin Calcium | |||
| IDO1 Inhibitor MK-7162 | |||
| NA17-A Antigen | |||
| Pamidronic Acid | |||
| Abiraterone Acetate | |||
| Tefinostat | |||
| Anti-CD38 Monoclonal Antibody SAR442085 | |||
| Bisantrene Hydrochloride | |||
| Toremifene Citrate | |||
| Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T | |||
| Shenqi Fuzheng Injection SQ001 | |||
| 12-Allyldeoxoartemisinin | |||
| Epratuzumab | |||
| DNA-PK/TOR Kinase Inhibitor CC-115 | |||
| Pimurutamab | |||
| WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401 | |||
| Chloroquinoxaline Sulfonamide | |||
| Anti-CD352 Antibody-drug Conjugate SGN-CD352A | |||
| Ipomeanol | |||
| Amifostine | |||
| Oraxol | |||
| Lutetium Lu 177 Satoreotide Tetraxetan | |||
| Alvespimycin | |||
| FGFR Inhibitor CPL304110 | |||
| Codrituzumab | |||
| IGF-methotrexate Conjugate | |||
| STING Agonist BMS-986301 | |||
| Aderbasib | |||
| Sapanisertib | |||
| Peposertib | |||
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088 | |||
| Anti-HER2-DM1 ADC B003 | |||
| EED Inhibitor MAK683 | |||
| Azaribine | |||
| Tivozanib | |||
| Dual IGF-1R/InsR Inhibitor BMS-754807 | |||
| FPV Vaccine CV301 | |||
| Rice Bran | |||
| Lactoferrin-derived Lytic Peptide LTX-315 | |||
| Anti-CD3/CD20 Bispecific Antibody GEN3013 | |||
| Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123 | |||
| Rhenium Re-186 Hydroxyethylidene Diphosphonate | |||
| Gandotinib | |||
| Anti-5T4 Antibody-drug Conjugate SYD1875 | |||
| Multi-mode Kinase Inhibitor EOC317 | |||
| Raf Kinase Inhibitor HM95573 | |||
| Auranofin | |||
| Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV | |||
| BTK Inhibitor DTRMWXHS-12 | |||
| ICT-121 Dendritic Cell Vaccine | |||
| BTK Inhibitor LOXO-305 | |||
| Afatinib | |||
| Microbiome GEN-001 | |||
| Anti-LAG-3 Monoclonal Antibody REGN3767 | |||
| Girodazole | |||
| Itraconazole Dispersion In Polymer Matrix | |||
| Ensituximab | |||
| CDK/JAK2/FLT3 Inhibitor TG02 Citrate | |||
| Lyso-Thermosensitive Liposome Doxorubicin | |||
| Recombinant Human Angiotensin Converting Enzyme 2 APN01 | |||
| Pegvisomant | |||
| Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777 | |||
| Emactuzumab | |||
| Serine/Threonine Kinase Inhibitor CBP501 | |||
| Imatinib Mesylate | |||
| Lirilumab | |||
| AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M | |||
| Ascrinvacumab | |||
| Anti-PD-L1 Monoclonal Antibody HLX20 | |||
| Fosbretabulin Tromethamine | |||
| PARP Inhibitor AZD2461 | |||
| Anti c-KIT Antibody-drug Conjugate LOP628 | |||
| c-Met Inhibitor JNJ-38877605 | |||
| Ansamitomicin P-3 | |||
| White Carrot | |||
| Everolimus Tablets for Oral Suspension | |||
| Pimasertib | |||
| Paclitaxel Ceribate | |||
| Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso | |||
| CD28/ICOS Antagonist ALPN-101 | |||
| BET Inhibitor RO6870810 | |||
| Quizartinib | |||
| Sirolimus | |||
| Herba Scutellaria Barbata | |||
| MK0731 | |||
| Bleomycin A2 | |||
| Teloxantrone | |||
| Brivanib | |||
| Oncolytic HSV-1 rQNestin34.5v.2 | |||
| Docetaxel/Ritonavir | |||
| Monoclonal Antibody A33 | |||
| Resminostat | |||
| Palifosfamide | |||
| Mifepristone | |||
| Tiomolibdate Choline | |||
| Porcupine Inhibitor RXC004 | |||
| N-Methylformamide | |||
| Dexamethason | |||
| Arginine Butyrate | |||
| Ruxolitinib Phosphate | |||
| St. John's Wort | |||
| Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88 | |||
| Dichloroallyl Lawsone | |||
| Resveratrol | |||
| Alanosine | |||
| Motesanib | |||
| Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053 | |||
| HM2/MMAE Antibody-Drug Conjugate ALT-P7 | |||
| Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H | |||
| Zinostatin Stimalamer | |||
| Anti-LAG-3 Monoclonal Antibody IBI-110 | |||
| Lonafarnib | |||
| Mannosylerythritol Lipid | |||
| Pibrozelesin Hydrobromide | |||
| Tenalisib | |||
| Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104 | |||
| Sagopilone | |||
| Diaziquone | |||
| Anti-ILDR2 Monoclonal Antibody BAY 1905254 | |||
| Tyrosinase:146-156 Peptide | |||
| CCR4 Inhibitor FLX475 | |||
| Hsp90 Inhibitor HSP990 | |||
| Tankyrase Inhibitor STP1002 | |||
| Asunercept | |||
| Anti-PSMA/CD3 Bispecific Antibody CCW702 | |||
| Epipodophyllotoxin Analog GL331 | |||
| LSD1 Inhibitor IMG-7289 | |||
| Berzosertib | |||
| LMB-9 Immunotoxin | |||
| Exicorilant | |||
| Enfortumab Vedotin | |||
| Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine | |||
| Azaserine | |||
| E2F1 Pathway Activator ARQ 171 | |||
| Niclosamide | |||
| mTORC1/mTORC2/DHFR Inhibitor ABTL0812 | |||
| Selective Estrogen Receptor Degrader SRN-927 | |||
| Fludarabine | |||
| Chaparrin | |||
| Immunomodulator OHR/AVR118 | |||
| Selective Cytokine Inhibitory Drug CC-1088 | |||
| Tirbanibulin | |||
| Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205 | |||
| MCL-1 Inhibitor ABBV-467 | |||
| MEK Inhibitor RO4987655 | |||
| Iso-fludelone | |||
| Enadenotucirev | |||
| Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623 | |||
| Zoptarelin Doxorubicin | |||
| Eflornithine Hydrochloride | |||
| CEA-targeting Agent RG6123 | |||
| Selective Estrogen Receptor Degrader AZD9496 | |||
| Feladilimab | |||
| Brivudine Phosphoramidate | |||
| Polatuzumab Vedotin | |||
| Canerpaturev | |||
| Anti-AGS-16 Monoclonal Antibody AGS-16M18 | |||
| Procarbazine | |||
| Anti-CD33 Antibody-drug Conjugate IMGN779 | |||
| Sodium Salicylate | |||
| Oglufanide Disodium | |||
| Monoclonal Antibody 11D10 | |||
| PRIMA-1 Analog APR-246 | |||
| Denenicokin | |||
| Anti-VEGFR3 Monoclonal Antibody IMC-3C5 | |||
| EGFR Inhibitor BIBX 1382 | |||
| TLR Agonist CADI-05 | |||
| Adecatumumab | |||
| Buserelin | |||
| Paclitaxel Injection Concentrate for Nanodispersion | |||
| Tyrosine Kinase Inhibitor OSI-930 | |||
| Vinblastine Sulfate | |||
| Infigratinib Mesylate | |||
| HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101 | |||
| Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b | |||
| Tacedinaline | |||
| Ralaniten Acetate | |||
| Carboplatin | |||
| Iberdomide | |||
| Anti-PD-L1 Monoclonal Antibody FAZ053 | |||
| Carmustine Sustained-Release Implant Wafer | |||
| Panitumumab | |||
| Tyrosine Kinase Inhibitor TL-895 | |||
| HPV-6-targeting Immunotherapeutic Vaccine INO-3106 | |||
| Anti-nf-P2X7 Antibody Ointment BIL-010t | |||
| Ranibizumab | |||
| Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641 | |||
| Iloprost | |||
| Oncolytic HSV-1 rRp450 | |||
| LOXL2 Inhibitor PAT-1251 | |||
| Daniquidone | |||
| Dabrafenib | |||
| DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151 | |||
| Daratumumab and Hyaluronidase-fihj | |||
| IDO/TDO Inhibitor HTI-1090 | |||
| Pomegranate Liquid Extract | |||
| Ex Vivo-expanded Autologous T Cells IMA101 | |||
| Dexamethasone Sodium Phosphate | |||
| Pegylated SN-38 Conjugate PLX038 | |||
| TSP-1 Mimetic Fusion Protein CVX-045 | |||
| RET Mutation/Fusion Inhibitor BLU-667 | |||
| Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome | |||
| NY-ESO-B | |||
| Pracinostat | |||
| Cytarabine Monophosphate Prodrug MB07133 | |||
| Xentuzumab | |||
| Nanoparticle-encapsulated Doxorubicin Hydrochloride | |||
| Gataparsen Sodium | |||
| Flumatinib | |||
| EGb761 | |||
| Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 | |||
| Palonosetron Hydrochloride | |||
| Abexinostat | |||
| Almurtide | |||
| Topical Celecoxib | |||
| Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein | |||
| Beta-Carotene | |||
| Naquotinib | |||
| MCL-1 Inhibitor AMG 176 | |||
| Fluorine F 18 Ara-G | |||
| SERD SHR9549 | |||
| DR5 HexaBody Agonist GEN1029 | |||
| Arsenic Trioxide | |||
| Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1 | |||
| Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459 | |||
| Foslinanib | |||
| APE1/Ref-1 Redox Inhibitor APX3330 | |||
| VEGF Inhibitor PTC299 | |||
| Intiquinatine | |||
| Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256 | |||
| Acronine | |||
| Metarrestin | |||
| Tipiracil Hydrochloride | |||
| PGLA/PEG Copolymer-Based Paclitaxel | |||
| Methionine Aminopeptidase 2 Inhibitor PPI-2458 | |||
| Bexmarilimab | |||
| Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx | |||
| Revdofilimab | |||
| Monoclonal Antibody 105AD7 Anti-idiotype Vaccine | |||
| Duligotuzumab | |||
| EGFR Mutant-specific Inhibitor ZN-e4 | |||
| Polyamine Transport Inhibitor AMXT-1501 Dicaprate | |||
| Estramustine | |||
| Telapristone | |||
| Artemisinin Dimer | |||
| Elacytarabine | |||
| c-Met Inhibitor MK8033 | |||
| Delolimogene Mupadenorepvec | |||
| p53-HDM2 Interaction Inhibitor MI-773 | |||
| Anti-CLDN6 Monoclonal Antibody ASP1650 | |||
| TIGIT-targeting Agent MK-7684 | |||
| Autologous Tumor Infiltrating Lymphocytes LN-144 | |||
| Anti-TROP2 Antibody-drug Conjugate SKB264 | |||
| Nurulimab | |||
| PI3K-alpha Inhibitor MEN1611 | |||
| Tranylcypromine Sulfate | |||
| Atuveciclib | |||
| Pinatuzumab Vedotin | |||
| Indibulin | |||
| Dovitinib Lactate | |||
| Audencel | |||
| Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A | |||
| Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001 | |||
| Nucleoside Analog DFP-10917 | |||
| pNGVL4a-CRT-E6E7L2 DNA Vaccine | |||
| Leucovorin Calcium | |||
| Ontorpacept | |||
| Esorubicin Hydrochloride | |||
| NA17.A2 Peptide Vaccine | |||
| Pasireotide | |||
| Rovalpituzumab Tesirine | |||
| Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528 | |||
| Rucaparib | |||
| Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100 | |||
| PIM Kinase Inhibitor LGH447 | |||
| Mitotenamine | |||
| Clarithromycin | |||
| ERK 1/2 Inhibitor ASTX029 | |||
| GM-CSF-encoding Oncolytic Adenovirus CGTG-102 | |||
| Idronoxil | |||
| Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010 | |||
| Alitretinoin | |||
| Anti-PD-L1/IL-15 Fusion Protein KD033 | |||
| Berberine Chloride | |||
| Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718 | |||
| MEK Inhibitor AZD8330 | |||
| Recombinant Fas Ligand | |||
| Anetumab Ravtansine | |||
| PI3K Inhibitor ACP-319 | |||
| Anti-PD-L1 Monoclonal Antibody A167 | |||
| Multikinase Inhibitor 4SC-203 | |||
| Folic Acid | |||
| Burosumab | |||
| Fc-engineered Anti-CD40 Agonist Antibody 2141-V11 | |||
| Semustine | |||
| Kunecatechins Ointment | |||
| Serclutamab Talirine | |||
| FGFR1/2/3 Inhibitor HMPL-453 | |||
| Natural Killer Cells ZRx101 | |||
| Selective Androgen Receptor Modulator RAD140 | |||
| Metatinib Tromethamine | |||
| Muscadine Grape Extract | |||
| Mibefradil | |||
| Rilotumumab | |||
| Salmonella VNP20009 | |||
| Pemetrexed Disodium | |||
| BCG Vaccine | |||
| Bozitinib | |||
| Bendamustine-containing Nanoparticle-based Formulation RXDX-107 | |||
| BTK Inhibitor CT-1530 | |||
| Inulin | |||
| Baricitinib | |||
| Indomethacin | |||
| PI3Kbeta Inhibitor AZD8186 | |||
| Aurora Kinase Inhibitor TTP607 | |||
| Aldoxorubicin | |||
| EZH2 Inhibitor CPI-1205 | |||
| Anti-PD-1 Monoclonal Antibody 609A | |||
| Gelonin | |||
| Ifetroban | |||
| CDC7 Kinase Inhibitor NMS-1116354 | |||
| Aminocamptothecin Colloidal Dispersion | |||
| 2,6-Diaminopurine | |||
| Yttrium Y 90 Daclizumab | |||
| Anti-myostatin Monoclonal Antibody LY2495655 | |||
| Herbimycin | |||
| Alacizumab Pegol | |||
| Synchrotope TA2M Plasmid DNA Vaccine | |||
| Dendritic Cell-targeting Lentiviral Vector ID-LV305 | |||
| Anti-CTLA-4 Monoclonal Antibody ONC-392 | |||
| Ambazone | |||
| Autologous Nectin-4/FAP-targeted CAR-T Cells | |||
| Pelitrexol | |||
| Talazoparib | |||
| STING Agonist SB 11285 | |||
| Matuzumab | |||
| Bivalent BRD4 Inhibitor AZD5153 | |||
| Iodine I 131 Monoclonal Antibody BC8 | |||
| Mosedipimod | |||
| Anti-BCMA/CD3 BiTE Antibody REGN5458 | |||
| Lumretuzumab | |||
| NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301 | |||
| Acyclic Nucleoside Phosphonate Prodrug ABI-1968 | |||
| Eflornithine | |||
| P-TEFb Inhibitor BAY1143572 | |||
| Batabulin Sodium | |||
| Protein Phosphatase 2A Inhibitor LB-100 | |||
| Anti-CEACAM5 Antibody-Drug Conjugate SAR408701 | |||
| 5-Fluoro-2-Deoxycytidine | |||
| 2-Ethylhydrazide | |||
| TLR Agonist BSG-001 | |||
| Nimotuzumab | |||
| Iodine I 131 Ethiodized Oil | |||
| Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 | |||
| Spebrutinib | |||
| Idetrexed | |||
| Vinblastine | |||
| 11C Topotecan | |||
| Budigalimab | |||
| Concentrated Lingzhi Mushroom Extract | |||
| pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2 | |||
| Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A | |||
| Zolbetuximab | |||
| Anti-FCRH5/CD3 BiTE Antibody BFCR4350A | |||
| 4-Thio-2-deoxycytidine | |||
| Encapsulated Rapamycin | |||
| Radix Angelicae Sinensis/Radix Astragali Herbal Supplement | |||
| ERK Inhibitor CC-90003 | |||
| Veliparib | |||
| Tigapotide | |||
| Carzelesin | |||
| Altiratinib | |||
| Orteronel | |||
| Esterified Estrogens | |||
| WT1-A10/AS01B Immunotherapeutic GSK2130579A | |||
| EGFR Inhibitor DBPR112 | |||
| Cyclophosphamide | |||
| Andecaliximab | |||
| PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521 | |||
| ARC Fusion Protein SL-279252 | |||
| Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2 | |||
| Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001 | |||
| Sofituzumab Vedotin | |||
| Anti-CSF1 Monoclonal Antibody PD-0360324 | |||
| Tamoxifen | |||
| Pasotuxizumab | |||
| Megestrol Acetate | |||
| Rolinsatamab Talirine | |||
| LMP7 Inhibitor M3258 | |||
| 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158 | |||
| Melphalan Flufenamide | |||
| STAT3 Inhibitor DSP-0337 | |||
| Antineoplaston AS2-1 | |||
| Recombinant Tumor Necrosis Factor-Alpha | |||
| Delanzomib | |||
| Anti-c-Met Monoclonal Antibody ARGX-111 | |||
| Retaspimycin | |||
| Roblitinib | |||
| Breflate | |||
| Paclitaxel-Loaded Polymeric Micelle | |||
| ERK1/2 Inhibitor LY3214996 | |||
| Safingol | |||
| Anti-LAG3 Monoclonal Antibody TSR-033 | |||
| Camrelizumab | |||
| Onartuzumab | |||
| Rigosertib | |||
| Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703 | |||
| LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164 | |||
| BRAF(V600E) Kinase Inhibitor RO5212054 | |||
| Belinostat | |||
| Balixafortide | |||
| Anti-TIGIT Monoclonal Antibody BMS-986207 | |||
| Pamidronate Disodium | |||
| Amrubicin Hydrochloride | |||
| Pan-Mutant-IDH1 Inhibitor Bay-1436032 | |||
| c-Met Inhibitor ABN401 | |||
| Ulocuplumab | |||
| TRPV6 Calcium Channel Inhibitor SOR-C13 | |||
| Anti-angiopoietin Monoclonal Antibody AMG 780 | |||
| Etidronate-Cytarabine Conjugate MBC-11 | |||
| CD11b Agonist GB1275 | |||
| Methotrexate Sodium | |||
| Serplulimab | |||
| Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19 | |||
| EGFR Inhibitor TY-9591 | |||
| Prinomastat | |||
| Calcitriol | |||
| Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001 | |||
| FAK Inhibitor GSK2256098 | |||
| Anti-TIM-3 Monoclonal Antibody INCAGN02390 | |||
| Taminadenant | |||
| Formestane | |||
| Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A | |||
| Enoticumab | |||
| Dendritic Cell Vaccine | |||
| Oral Myoma Vaccine V3-myoma | |||
| Aurora A Kinase Inhibitor TAS-119 | |||
| Lenvatinib Mesylate | |||
| Anti-CD20 Monoclonal Antibody TL011 | |||
| Beta-Glucan | |||
| Anti-OX40 Hexavalent Agonist Antibody INBRX-106 | |||
| XIAP Antisense Oligonucleotide AEG35156 | |||
| Xiaoai Jiedu Decoction | |||
| Toll-like Receptor 7 Agonist DSP-0509 | |||
| Heterodimeric Interleukin-15 | |||
| hTERT-encoding DNA Vaccine INVAC-1 | |||
| I 131 Monoclonal Antibody F19 | |||
| Linoleyl Carbonate-Paclitaxel | |||
| Superoxide Dismutase Mimetic GC4711 | |||
| Carlumab | |||
| Iodine I 131 Apamistamab | |||
| Namirotene | |||
| Broccoli Sprout/Broccoli Seed Extract Supplement | |||
| Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S | |||
| Murizatoclax | |||
| Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes | |||
| Prostaglandin E2 EP4 Receptor Inhibitor AN0025 | |||
| Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968 | |||
| Polymer-conjugated IL-15 Receptor Agonist NKTR-255 | |||
| Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 | |||
| Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01 | |||
| Gimatecan | |||
| Rexinoid NRX 194204 | |||
| Dimethylmyleran | |||
| Tetrathiomolybdate | |||
| Anti-CTLA-4 Monoclonal Antibody REGN4659 | |||
| Dubermatinib | |||
| Melapuldencel-T | |||
| Iodine I 131 Rituximab | |||
| Anti-CD123 ADC IMGN632 | |||
| Bruceanol E | |||
| Anti-EGFR Monoclonal Antibody Mixture MM-151 | |||
| Folate Receptor-Targeted Tubulysin Conjugate EC1456 | |||
| Ditiocarb | |||
| TLC ELL-12 | |||
| Anti-PD-L1 Monoclonal Antibody SHR-1316 | |||
| Clinical Trial | |||
| CD73 Inhibitor LY3475070 | |||
| HDAC Inhibitor CKD-581 | |||
| Phosphorus P-32 | |||
| Folitixorin | |||
| Mechlorethamine | |||
| Recombinant Erwinia asparaginase JZP-458 | |||
| Magrolimab | |||
| Luminespib Mesylate | |||
| Rosmantuzumab | |||
| Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307 | |||
| Zorubicin | |||
| Sumoylation Inhibitor TAK-981 | |||
| Smoothened Antagonist BMS-833923 | |||
| Oncolytic HSV-1 G207 | |||
| Anti-BCMA Antibody-drug Conjugate AMG 224 | |||
| Sotrastaurin | |||
| Larotrectinib | |||
| Matrix Metalloproteinase Inhibitor MMI270 | |||
| Azapicyl | |||
| Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044 | |||
| Vismodegib | |||
| Praluzatamab Ravtansine | |||
| Anti-CD40 Monoclonal Antibody SEA-CD40 | |||
| IAP Inhibitor AT-406 | |||
| Etaracizumab | |||
| ssRNA-based Immunomodulator CV8102 | |||
| Thorium Th 227 Anetumab | |||
| Afatinib Dimaleate | |||
| Shark Cartilage | |||
| Iridium Ir 192 | |||
| Teloxantrone Hydrochloride | |||
| Innate Immunostimulator rBBX-01 | |||
| MET Tyrosine Kinase Inhibitor SGX523 | |||
| Asulacrine | |||
| Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017 | |||
| Tislelizumab | |||
| ALK Inhibitor WX-0593 | |||
| Docetaxel Polymeric Micelles | |||
| Vinflunine Ditartrate | |||
| CDK2/5/9 Inhibitor CYC065 | |||
| Sodium Metaarsenite | |||
| PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate | |||
| Decitabine | |||
| Anti-EGFR Monoclonal Antibody HLX-07 | |||
| FACT Complex-targeting Curaxin CBL0137 | |||
| Anti-CTLA4 Antibody Fc Fusion Protein KN044 | |||
| Depatuxizumab | |||
| Samalizumab | |||
| Sitravatinib | |||
| Resveratrol Formulation SRT501 | |||
| Anti-IL-13 Humanized Monoclonal Antibody TNX-650 | |||
| Cyproterone Acetate | |||
| Monoclonal Antibody 7C11 | |||
| Inositol | |||
| Rebimastat | |||
| Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 | |||
| Erastin Analogue PRLX 93936 | |||
| Nicotinamide Riboside | |||
| Clivatuzumab | |||
| Shu Yu Wan Formula | |||
| CDK8/19 Inhibitor SEL 120 | |||
| Piperine Extract (Standardized) | |||
| CYP11A1 inhibitor ODM-208 | |||
| Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1 | |||
| AXL Inhibitor SLC-391 | |||
| Troxacitabine | |||
| Manelimab | |||
| Idarubicin | |||
| Pingyangmycin | |||
| Telratolimod | |||
| Onalespib | |||
| Talampanel | |||
| Dulanermin | |||
| Itacitinib | |||
| Falimarev | |||
| PARP7 Inhibitor RBN-2397 | |||
| Recombinant MAGE-3.1 Antigen | |||
| ERK Inhibitor MK-8353 | |||
| Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A | |||
| Yttrium Y 90 Glass Microspheres | |||
| Anti-CTLA-4 Monoclonal Antibody AGEN1181 | |||
| Eniluracil/5-FU Combination Tablet | |||
| Imetelstat Sodium | |||
| mTOR Kinase Inhibitor AZD8055 | |||
| Aclacinomycin B | |||
| Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001 | |||
| Piroxantrone Hydrochloride | |||
| Pegilodecakin | |||
| Talacotuzumab | |||
| Carzinophilin | |||
| Antineoplastic Vaccine | |||
| Binetrakin | |||
| Iodine I 131 MIP-1095 | |||
| Agonistic Anti-OX40 Monoclonal Antibody MEDI6469 | |||
| PLK1 Inhibitor CYC140 | |||
| Gamma-Secretase Inhibitor LY3039478 | |||
| Astuprotimut-R | |||
| Birabresib | |||
| Cathelicidin LL-37 | |||
| Irinotecan | |||
| Suramin Sodium | |||
| Perfosfamide | |||
| Anti-AXL/PBD Antibody-drug Conjugate ADCT-601 | |||
| XPO1 Inhibitor SL-801 | |||
| Mesna | |||
| Recombinant Fractalkine | |||
| Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM | |||
| Allosteric ErbB Inhibitor BDTX-189 | |||
| Gilteritinib Fumarate | |||
| CD20-CD19 Compound CAR T Cells | |||
| CDK4/6 Inhibitor SHR6390 | |||
| ALK Inhibitor RO5424802 | |||
| Anti-CD137 Agonistic Monoclonal Antibody LVGN6051 | |||
| Anti-CD47 Monoclonal Antibody SRF231 | |||
| Oxaliplatin Eluting Beads | |||
| Zotiraciclib Citrate | |||
| Gossypol | |||
| Becatecarin | |||
| BET Inhibitor FT-1101 | |||
| Sparfosate Sodium | |||
| Nivolumab | |||
| Neoantigen Vaccine GEN-009 | |||
| Anti-CD40L Fc-Fusion Protein BMS-986004 | |||
| Vascular Disrupting Agent ZD6126 | |||
| Temoporfin | |||
| Milademetan Tosylate | |||
| Elgemtumab | |||
| Anti-HER2-vc0101 ADC PF-06804103 | |||
| Tisagenlecleucel | |||
| Autologous Anti-FLT3 CAR T Cells AMG 553 | |||
| Hexaminolevulinate | |||
| Asaley | |||
| mTOR Kinase Inhibitor OSI-027 | |||
| TLR9 Agonist AST-008 | |||
| BET Inhibitor BAY1238097 | |||
| Echinomycin | |||
| Golvatinib | |||
| Tretazicar | |||
| Givinostat | |||
| Adenoviral Brachyury Vaccine ETBX-051 | |||
| Rituximab and Hyaluronidase Human | |||
| Recombinant Interleukin-12 | |||
| MetAP2 Inhibitor APL-1202 | |||
| Short Chain Fatty Acid HQK-1004 | |||
| FGFR Inhibitor TAS-120 | |||
| Melphalan Hydrochloride | |||
| Bufalin | |||
| Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202 | |||
| Budotitane | |||
| Glucocorticoid Receptor Antagonist ORIC-101 | |||
| Mureletecan | |||
| Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01 | |||
| Mycophenolic Acid | |||
| Src Kinase Inhibitor AP 23846 | |||
| Fadraciclib | |||
| ASP4132 | |||
| Anti-GnRH Vaccine PEP223 | |||
| Bosutinib | |||
| BET Inhibitor INCB054329 | |||
| Darleukin | |||
| Arnebia Indigo Jade Pearl Topical Cream | |||
| HPV-16 E6 Peptides Vaccine/Candida albicans Extract | |||
| Puromycin | |||
| Tezacitabine | |||
| Tipapkinogene Sovacivec | |||
| Ancitabine Hydrochloride | |||
| Cabazitaxel | |||
| Tomato-Soy Juice | |||
| MKC-1 | |||
| Ilixadencel | |||
| Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327 | |||
| Entospletinib | |||
| Cereblon Modulator CC-90009 | |||
| Anthrapyrazole | |||
| Filgotinib | |||
| Pegargiminase | |||
| Vorsetzumab Mafodotin | |||
| Rubitecan | |||
| Anti-CD20 Monoclonal Antibody SCT400 | |||
| Selective Estrogen Receptor Degrader LSZ102 | |||
| Hafnium Oxide-containing Nanoparticles NBTXR3 | |||
| Monoclonal Antibody D6.12 | |||
| Pentamustine | |||
| Anti-NaPi2b Monoclonal Antibody XMT-1535 | |||
| Lipid Nanoparticle Encapsulated OX40L mRNA-2416 | |||
| Vandetanib | |||
| GSK-3 Inhibitor 9-ING-41 | |||
| Akt Inhibitor MK2206 | |||
| Bcr-Abl Kinase Inhibitor K0706 | |||
| RORgamma Agonist LYC-55716 | |||
| Anti-CD27 Agonistic Monoclonal Antibody MK-5890 | |||
| FAP/4-1BB-targeting DARPin MP0310 | |||
| Tanibirumab | |||
| MDM2 Inhibitor KRT-232 | |||
| Antibody-drug Conjugate SC-003 | |||
| Flotetuzumab | |||
| Soy Protein Isolate | |||
| Retinoid 9cUAB30 | |||
| Androgen Receptor Degrader CC-94676 | |||
| Radiolabeled CC49 | |||
| Serdemetan | |||
| CYP17/CYP11B2 Inhibitor LAE001 | |||
| FAK Inhibitor PF-00562271 | |||
| Tucotuzumab Celmoleukin | |||
| IAP Inhibitor HGS1029 | |||
| Yttrium Y 90 Basiliximab | |||
| Carfilzomib | |||
| Galamustine | |||
| STING-activating Cyclic Dinucleotide Agonist MIW815 | |||
| Donafenib | |||
| Ribozyme RPI.4610 | |||
| Anti-PD-L1 Monoclonal Antibody IMC-001 | |||
| Inebilizumab | |||
| Ensartinib | |||
| Personalized Neoepitope Yeast Vaccine YE-NEO-001 | |||
| Monoclonal Antibody 11D10 Anti-Idiotype Vaccine | |||
| Etigilimab | |||
| Vofatamab | |||
| Long-acting Release Pasireotide | |||
| PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1 | |||
| Acodazole | |||
| Brimonidine Tartrate Nanoemulsion OCU-300 | |||
| Metoprine | |||
| Pegylated Liposomal Mitomycin C Lipid-based Prodrug | |||
| Dusigitumab | |||
| mRNA-derived KRAS-targeted Vaccine V941 | |||
| Momelotinib | |||
| Cisplatin Liposomal | |||
| Topotecan Hydrochloride | |||
| mTORC 1/2 Inhibitor LXI-15029 | |||
| Gemcitabine-Releasing Intravesical System | |||
| Motexafin Lutetium | |||
| Doxorubicin-HPMA Conjugate | |||
| Autologous Tumor Infiltrating Lymphocytes MDA-TIL | |||
| Gemcitabine | |||
| Pan-FGFR Inhibitor LY2874455 | |||
| Pioglitazone | |||
| Protein Kinase C Inhibitor IDE196 | |||
| Tetrahydrouridine | |||
| Gedatolisib | |||
| Xeloda | |||
| Amcasertib | |||
| Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1 | |||
| Actinium Ac 225 Lintuzumab | |||
| TRAIL Receptor Agonist ABBV-621 | |||
| Mivebresib | |||
| Diethylnorspermine | |||
| DHEA Mustard | |||
| Copanlisib Hydrochloride | |||
| Deuterated Enzalutamide | |||
| Ragifilimab | |||
| Plocabulin | |||
| Allogeneic Anti-BCMA-CAR T-cells PBCAR269A | |||
| Topical Gemcitabine Hydrochloride | |||
| Devimistat | |||
| Fluorouracil | |||
| Anti-human GITR Monoclonal Antibody TRX518 | |||
| Zorifertinib | |||
| pan-PIM Kinase Inhibitor AZD1208 | |||
| Perillyl Alcohol | |||
| Atiprimod Dimaleate | |||
| Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142 | |||
| Bcr-Abl Kinase Inhibitor PF-114 | |||
| Anti-BCMA Antibody SEA-BCMA | |||
| Tucidinostat | |||
| Anti-c-KIT Monoclonal Antibody CDX 0158 | |||
| Lapachone | |||
| Carubicin | |||
| Attenuated Listeria monocytogenes CRS-100 | |||
| Rosabulin | |||
| Activin Type 2B Receptor Fc Fusion Protein STM 434 | |||
| Chimeric Monoclonal Antibody 81C6 | |||
| Anti-CD47 Monoclonal Antibody IMC-002 | |||
| DNA-PK/PI3K-delta Inhibitor BR101801 | |||
| Anti-alpha5beta1 Integrin Antibody MINT1526A | |||
| Anti-PLGF Monoclonal Antibody TB-403 | |||
| Raloxifene | |||
| Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A | |||
| Hedgehog Inhibitor IPI-609 | |||
| Inecalcitol | |||
| Vinorelbine Tartrate Emulsion | |||
| Tamrintamab Pamozirine | |||
| Virulizin | |||
| Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002 | |||
| Darinaparsin | |||
| Pelareorep | |||
| Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C | |||
| Salirasib | |||
| Membrane-Disrupting Peptide EP-100 | |||
| Selective Estrogen Receptor Degrader AZD9833 | |||
| Fluvastatin Sodium | |||
| Anti-EGFR Monoclonal Antibody CPGJ 602 | |||
| Cositecan | |||
| Anti-CD47 Monoclonal Antibody AO-176 | |||
| Nimesulide-Hyaluronic Acid Conjugate CA102N | |||
| Digoxin | |||
| Pegdinetanib | |||
| IL4-Pseudomonas Exotoxin Fusion Protein MDNA55 | |||
| Epitiostanol | |||
| Simlukafusp Alfa | |||
| 14C BMS-275183 | |||
| Anti-IL-8 Monoclonal Antibody BMS-986253 | |||
| Ganoderma lucidum Spores Powder Capsule | |||
| Methylprednisolone Acetate | |||
| Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG | |||
| Apalutamide | |||
| Porcupine Inhibitor XNW7201 | |||
| Androgen Antagonist APC-100 | |||
| Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12 | |||
| Anti-CD47 Monoclonal Antibody TJC4 | |||
| Aerosolized Aldesleukin | |||
| CXCR4 Antagonist USL311 | |||
| Lung-targeted Immunomodulator QBKPN | |||
| Oral Pancreatic Cancer Vaccine V3-P | |||
| Iodine I 131 IPA | |||
| Anti-Met Monoclonal Antibody Mixture Sym015 | |||
| Angiogenesis Inhibitor JI-101 | |||
| Angiopoietin-2-specific Fusion Protein PF-04856884 | |||
| Prexasertib | |||
| Synthetic Hypericin | |||
| Hydroxytyrosol | |||
| Esorubicin | |||
| Pancratistatin | |||
| C-myb Antisense Oligonucleotide G4460 | |||
| Eicosapentaenoic Acid | |||
| Laprituximab Emtansine | |||
| Fazarabine | |||
| Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130 | |||
| Felzartamab | |||
| Patritumab Deruxtecan | |||
| Liposomal Cytarabine | |||
| Plicamycin | |||
| Monoclonal Microbial EDP1503 | |||
| Topical Potassium Dobesilate | |||
| Silicon Phthalocyanine 4 | |||
| Topsalysin | |||
| Submicron Particle Paclitaxel Sterile Suspension | |||
| Prohibitin-Targeting Peptide 1 | |||
| Omacetaxine Mepesuccinate | |||
| Ipatasertib | |||
| Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201 | |||
| mRNA-Derived Prostate Cancer Vaccine CV9103 | |||
| CCR2 Antagonist CCX872-B | |||
| Dienogest | |||
| MEK Inhibitor CI-1040 | |||
| Nimustine | |||
| Treosulfan | |||
| Monoclonal Antibody 3622W94 | |||
| BET Inhibitor BMS-986158 | |||
| Heparan Sulfate Glycosaminoglycan Mimetic M402 | |||
| Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126 | |||
| Asciminib | |||
| Tubulin Polymerization Inhibitor AEZS 112 | |||
| Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01 | |||
| Dacarbazine | |||
| Onvansertib | |||
| Didox | |||
| Carotuximab | |||
| Varlitinib Tosylate | |||
| Topical Trichloroacetic Acid | |||
| Edelfosine | |||
| Aryl Hydrocarbon Receptor Inhibitor IK-175 | |||
| Abemaciclib | |||
| Pamiparib | |||
| Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate | |||
| Folate-FITC | |||
| BRAF Inhibitor BGB-3245 | |||
| Avadomide | |||
| Bazlitoran | |||
| 2-Deoxy-D-glucose | |||
| Anti-CD19/CD22 CAR NK Cells | |||
| Tolebrutinib | |||
| Autologous TCR-engineered T-cells IMA203 | |||
| Resiquimod Topical Gel | |||
| Bromocriptine Mesylate | |||
| Belotecan Hydrochloride | |||
| Heparin Derivative SST0001 | |||
| Microtubule Inhibitor SCB01A | |||
| Letetresgene Autoleucel | |||
| Navy Bean Powder | |||
| APC8015F | |||
| Notch Signaling Pathway Inhibitor MK0752 | |||
| Anti-DR5 Agonistic Monoclonal Antibody INBRX-109 | |||
| LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1 | |||
| Serabelisib | |||
| Thioureidobutyronitrile | |||
| Copanlisib | |||
| Derazantinib | |||
| Rhizoxin | |||
| Methazolamide | |||
| Risperidone Formulation in Rumenic Acid | |||
| Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody | |||
| Anti-CD40 Agonist Monoclonal Antibody ABBV-927 | |||
| Molibresib | |||
| Tropomyosin Receptor Kinase Inhibitor AZD7451 | |||
| Dezaguanine | |||
| Andrographolide | |||
| Odronextamab | |||
| Gonadotropin-releasing Hormone Analog | |||
| SRPK1/ABCG2 Inhibitor SCO-101 | |||
| Staphylococcal Enterotoxin B | |||
| Anti-EGFRvIII/CD3 BiTE Antibody AMG 596 | |||
| Etanidazole | |||
| Atezolizumab | |||
| Anti-Ribonucleoprotein Antibody ATRC-101 | |||
| Mogamulizumab | |||
| JNK Inhibitor CC-401 | |||
| Denibulin Hydrochloride | |||
| Danvatirsen | |||
| Anti-HBEGF Monoclonal Antibody U3-1565 | |||
| Anthramycin | |||
| Mechlorethamine Hydrochloride Gel | |||
| Amino Acid Injection | |||
| Trastuzumab | |||
| Melphalan | |||
| FGFR4 Antagonist INCB062079 | |||
| BTK Inhibitor HZ-A-018 | |||
| Recombinant Bacterial Minicells VAX014 | |||
| Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA | |||
| Napabucasin | |||
| XIAP/cIAP1 Antagonist ASTX660 | |||
| Oprozomib | |||
| Nesvacumab | |||
| Nemorubicin | |||
| Actinomycin F1 | |||
| 2-Methoxyestradiol | |||
| Anti-VEGF/ANG2 Nanobody BI 836880 | |||
| Encorafenib | |||
| Parsaclisib | |||
| Wnt-5a Mimic Hexapeptide Foxy-5 | |||
| Anti-HER2 Monoclonal Antibody B002 | |||
| Pyruvate Kinase Inhibitor TLN-232 | |||
| Methoxsalen | |||
| Lurtotecan Liposome | |||
| Chromomycin A3 | |||
| Topoisomerase-II Inhibitor Racemic XK469 | |||
| Pepinemab | |||
| FLT3/KIT/CSF1R Inhibitor NMS-03592088 | |||
| Elisidepsin | |||
| Lexibulin | |||
| Immunocytokine NHS-IL2-LT | |||
| Anti-CD19 Antibody-drug Conjugate SGN-CD19B | |||
| Mixed Bacteria Vaccine | |||
| Vitamin D3 Analogue ILX23-7553 | |||
| Imetelstat | |||
| 4'-Iodo-4'-Deoxydoxorubicin | |||
| Commensal Bacterial Strain Formulation VE800 | |||
| Engineered Human Umbilical Vein Endothelial Cells AB-205 | |||
| Rosiglitazone Maleate | |||
| Curcumin | |||
| Mocetinostat | |||
| Paclitaxel Vitamin E-Based Emulsion | |||
| Envafolimab | |||
| Ras Peptide CYS | |||
| Ertumaxomab | |||
| Parsatuzumab | |||
| Aldesleukin | |||
| Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120 | |||
| VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220 | |||
| Mitoxantrone Hydrochloride | |||
| Anti-VEGFC Monoclonal Antibody VGX-100 | |||
| Glioblastoma Cancer Vaccine ERC1671 | |||
| LMB-7 Immunotoxin | |||
| Lead Pb 212 TCMC-trastuzumab | |||
| Akt Inhibitor LY2780301 | |||
| Fluorodopan | |||
| Trebananib | |||
| MAGE-A3 Peptide Vaccine | |||
| SBIL-2 | |||
| Vascular Disrupting Agent BNC105 | |||
| Mirdametinib | |||
| Anti-GCC Antibody-Drug Conjugate MLN0264 | |||
| Galocitabine | |||
| Burixafor | |||
| Actinomycin C2 | |||
| Opolimogene Capmilisbac | |||
| Hydralazine Hydrochloride | |||
| Fosbretabulin Disodium | |||
| 4-Nitroestrone 3-Methyl Ether | |||
| Anti-GD2 Monoclonal Antibody hu14.18K322A | |||
| Autologous BCMA-targeted CAR T Cells CC-98633 | |||
| Lutetium Lu-177 PSMA-R2 | |||
| Thiodiglycol | |||
| Adenosine A2A Receptor Antagonist AZD4635 | |||
| Modified Vitamin D Binding Protein Macrophage Activator EF-022 | |||
| Anti-CD74 Antibody-drug Conjugate STRO-001 | |||
| PI3K/mTOR Kinase Inhibitor VS-5584 | |||
| Methyl-5-Aminolevulinate Hydrochloride Cream | |||
| Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300 | |||
| CDK7 Inhibitor SY-5609 | |||
| Levothyroxine | |||
| Bosutinib Monohydrate | |||
| Pan-TRK Inhibitor NOV1601 | |||
| Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107 | |||
| VEGFR Inhibitor KRN951 | |||
| Autologous Genetically-modified MAGE-A4 C1032 T Cells | |||
| Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1 | |||
| Tiomolibdate Diammonium | |||
| Cediranib Maleate | |||
| Recombinant Erythropoietin | |||
| Bafetinib | |||
| Monoclonal Antibody RAV12 | |||
| Gentuximab | |||
| Cirmtuzumab | |||
| Immunomodulator LAM-003 | |||
| Azotomycin | |||
| PD-1 Inhibitor | |||
| Bovine Cartilage | |||
| Not Reported | |||
| Roniciclib | |||
| Recombinant Human Endostatin | |||
| Hematoporphyrin Derivative | |||
| Huang Lian | |||
| Mitoclomine | |||
| Cyclopentenyl Cytosine | |||
| Ieramilimab | |||
| BRAF Inhibitor | |||
| Selective Estrogen Receptor Modulator TAS-108 | |||
| Ribociclib | |||
| Dilpacimab | |||
| Gastrin Immunotoxin | |||
| Broad-Spectrum Human Papillomavirus Vaccine V505 | |||
| Fosifloxuridine Nafalbenamide | |||
| Golotimod | |||
| Autologous Tumor Infiltrating Lymphocytes LN-145-S1 | |||
| HDAC inhibitor CG200745 | |||
| N-dihydrogalactochitosan | |||
| Selpercatinib | |||
| 5-Aza-4'-thio-2'-deoxycytidine | |||
| Protein Arginine Methyltransferase 5 Inhibitor PF-06939999 | |||
| Selective Estrogen Receptor Degrader LX-039 | |||
| Ganglioside GD2 | |||
| Triaziquone | |||
| Bis(choline)tetrathiomolybdate | |||
| Trastuzumab Emtansine | |||
| Savolitinib | |||
| Enzastaurin | |||
| Anti-CD26 Monoclonal Antibody YS110 | |||
| Urokinase-Derived Peptide A6 | |||
| Vosaroxin | |||
| EGFR/HER2 Inhibitor DZD9008 | |||
| Teprotumumab | |||
| Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062 | |||
| PARP Inhibitor NMS-03305293 | |||
| IDO-1 Inhibitor LY3381916 | |||
| Autologous Dendritic Cell-based Immunotherapeutic AV0113 | |||
| Ras Inhibitor | |||
| Anti-VEGFR2 Monoclonal Antibody HLX06 | |||
| Enavatuzumab | |||
| RFT5-dgA Immunotoxin IMTOX25 | |||
| 9-Ethyl 6-Mercaptopurine | |||
| Vadimezan | |||
| Defactinib | |||
| Fluvastatin | |||
| Anti-HER3 Monoclonal Antibody GSK2849330 | |||
| Pyroxamide | |||
| Cord Blood-derived Expanded Natural Killer Cells PNK-007 | |||
| Iodine I 131 Omburtamab | |||
| Caracemide | |||
| Irofulven | |||
| Broxuridine | |||
| Solitomab | |||
| Selinexor | |||
| Zalcitabine | |||
| Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118 | |||
| Crolibulin | |||
| Verubulin | |||
| Selumetinib | |||
| Rosuvastatin | |||
| Acalabrutinib | |||
| Interferon Alfacon-1 | |||
| Trigriluzole | |||
| Pilaralisib | |||
| Cedazuridine | |||
| Tecogalan Sodium | |||
| Antibody-drug Conjugate MEDI7247 | |||
| Anti-GCC Antibody-Drug Conjugate TAK-164 | |||
| Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108 | |||
| Brentuximab Vedotin | |||
| Anti-GD2 Monoclonal Antibody MORAb-028 | |||
| Progestational IUD | |||
| Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502 | |||
| MET Tyrosine Kinase Inhibitor BMS-777607 | |||
| BET Inhibitor ABBV-744 | |||
| Multi-epitope HER2 Peptide Vaccine TPIV100 | |||
| Liposomal Curcumin | |||
| Panobinostat | |||
| Anti-PD-L1 Monoclonal Antibody LY3300054 | |||
| AXL/ FLT3/VEGFR2 Inhibitor KC1036 | |||
| Doxorubicin Hydrochloride | |||
| PARP 1/2 Inhibitor NOV1401 | |||
| Anti-VEGFR2 Monoclonal Antibody MSB0254 | |||
| Tabelecleucel | |||
| Tocladesine | |||
| Alvocidib Hydrochloride | |||
| Anti-CD70 CAR-expressing T Lymphocytes | |||
| Thiotepa | |||
| Talactoferrin Alfa | |||
| Imaradenant | |||
| PI3K/mTOR Kinase Inhibitor WXFL10030390 | |||
| Androgen Receptor Inhibitor EPI-7386 | |||
| Pomegranate Juice | |||
| Peplomycin | |||
| ISS 1018 CpG Oligodeoxynucleotide | |||
| TSP-1 Mimetic ABT-510 | |||
| Actinium Ac 225-FPI-1434 | |||
| Anti-Met/EGFR Monoclonal Antibody LY3164530 | |||
| Catumaxomab | |||
| Rose Bengal Solution PV-10 | |||
| Deslorelin Acetate | |||
| Pixantrone | |||
| Rabusertib | |||
| Anti-CD30/CD16A Monoclonal Antibody AFM13 | |||
| Dexrazoxane Hydrochloride | |||
| Vadastuximab Talirine | |||
| Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05 | |||
| Cetrelimab | |||
| Mycobacterium w | |||
| CXC Chemokine Receptor 2 Antagonist AZD5069 | |||
| Marcellomycin | |||
| NTRK/ROS1 Inhibitor DS-6051b | |||
| Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101 | |||
| Alsevalimab | |||
| Tinzaparin Sodium | |||
| Liposome | |||
| Pan-KRAS Inhibitor BI 1701963 | |||
| Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020 | |||
| VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813 | |||
| Vindesine | |||
| Nanoparticle-based Paclitaxel Suspension | |||
| Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202 | |||
| Allogeneic Anti-CD20 CAR T-cells LUCAR-20S | |||
| CDK Inhibitor SNS-032 | |||
| Seliciclib | |||
| Anti-CD37 Monoclonal Antibody BI 836826 | |||
| Anti-PD-L1 Monoclonal Antibody CK-301 | |||
| Allogeneic Natural Killer Cell Line MG4101 | |||
| CSF-1R Inhibitor BLZ945 | |||
| Linperlisib | |||
| Lefitolimod | |||
| Cilengitide | |||
| Calculus bovis/Moschus/Olibanum/Myrrha Capsule | |||
| MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells | |||
| Galeterone | |||
| Iniparib | |||
| Moxetumomab Pasudotox | |||
| Recombinant Thyrotropin Alfa | |||
| Methyltestosterone | |||
| Belvarafenib | |||
| UAE Inhibitor TAK-243 | |||
| AE37 Peptide/GM-CSF Vaccine | |||
| Anti-TIGIT Monoclonal Antibody AB154 | |||
| Yttrium Y-90 Ibritumomab Tiuxetan | |||
| HDAC Inhibitor CHR-2845 | |||
| Temarotene | |||
| Oncolytic Virus RP1 | |||
| Cibisatamab | |||
| Anti-PD-1 Monoclonal Antibody MEDI0680 | |||
| Nelipepimut-S | |||
| Anti-PSMA/PBD ADC MEDI3726 | |||
| Ocaratuzumab | |||
| CpG Oligodeoxynucleotide GNKG168 | |||
| Coxsackievirus V937 | |||
| Troxacitabine Nucleotide Prodrug MIV-818 | |||
| CHK1 Inhibitor PF-477736 | |||
| BTK Inhibitor M7583 | |||
| Anti-PD-1 Monoclonal Antibody TSR-042 | |||
| Lazertinib | |||
| Milk Thistle | |||
| Fluorouracil-E Therapeutic Implant | |||
| Gilteritinib | |||
| Palbociclib | |||
| CSF1R Inhibitor DCC-3014 | |||
| Autologous CD20-4SCAR-expressing T-cells 4SCAR20 | |||
| I 131 Monoclonal Antibody Lym-1 | |||
| EGFR/HER2 Inhibitor AP32788 | |||
| Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439 | |||
| Polysaccharide-K | |||
| Avapritinib | |||
| Nemorubicin Hydrochloride | |||
| Immunotherapeutic Combination Product CMB305 | |||
| Anti-VEGF Anticalin PRS-050-PEG40 | |||
| Monoclonal Antibody MX35 F(ab')2 | |||
| BRAF Inhibitor PLX8394 | |||
| RSK1-4 Inhibitor PMD-026 | |||
| Amonafide L-Malate | |||
| Anti-CD19-DM4 Immunoconjugate SAR3419 | |||
| Streptonigrin | |||
| Phaleria macrocarpa Extract DLBS-1425 | |||
| 2-Hydroxyflutamide Depot | |||
| MDM2 Inhibitor AMG-232 | |||
| Anti-TGF-beta Monoclonal Antibody NIS793 | |||
| HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 | |||
| Osimertinib | |||
| MAGE-10.A2 | |||
| HIF2a RNAi ARO-HIF2 | |||
| Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981 | |||
| Irinotecan Hydrochloride | |||
| Rociletinib | |||
| HPV DNA Plasmids Therapeutic Vaccine VGX-3100 | |||
| Babaodan Capsule | |||
| Elesclomol | |||
| Pumitepa | |||
| Trimelamol | |||
| Aminocamptothecin | |||
| Nanoparticle Albumin-Bound Rapamycin | |||
| Mitosis Inhibitor T 1101 Tosylate | |||
| FAK/ALK/ROS1 Inhibitor APG-2449 | |||
| Taurultam Analogue GP-2250 | |||
| Anti-BCMA Antibody-drug Conjugate GSK2857916 | |||
| Recombinant Luteinizing Hormone | |||
| Retinyl Palmitate | |||
| RARalpha Agonist IRX5183 | |||
| Iodine I 131 Monoclonal Antibody F16SIP | |||
| MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1 | |||
| Engineered Toxin Body Targeting CD38 TAK-169 | |||
| Nedisertib | |||
| INO-1001 | |||
| Liposomal c-raf Antisense Oligonucleotide | |||
| Oxaliplatin | |||
| Regorafenib | |||
| Anti-PD-1 Monoclonal Antibody MGA012 | |||
| CXCR2 Antagonist QBM076 | |||
| Tretinoin | |||
| Sulfatinib | |||
| Anti-CXCR4 Monoclonal Antibody PF-06747143 | |||
| Ciclopirox Prodrug CPX-POM | |||
| Pyrazoloacridine | |||
| Rindopepimut | |||
| 2-Methoxyestradiol Nanocrystal Colloidal Dispersion | |||
| Indoximod Prodrug NLG802 | |||
| GS/pan-Notch Inhibitor AL101 | |||
| Src Kinase Inhibitor KX2-391 Ointment | |||
| Terfluranol | |||
| Anti-TIGIT Monoclonal Antibody OMP-313M32 | |||
| Allogeneic Irradiated Melanoma Cell Vaccine CSF470 | |||
| Folate Receptor Targeted Epothilone BMS753493 | |||
| Daratumumab | |||
| Lutetium Lu 177-DOTA-EB-TATE | |||
| Autologous Deep IL-15 Primed T-cells TRQ15-01 | |||
| Spiroplatin | |||
| Iratumumab | |||
| Elesclomol Sodium | |||
| Pegvorhyaluronidase Alfa | |||
| Modakafusp Alfa | |||
| Sulindac | |||
| Cedefingol | |||
| Sedoxantrone Trihydrochloride | |||
| Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352 | |||
| Cedazuridine/Decitabine Combination Agent ASTX727 | |||
| Pentoxifylline | |||
| Iodine I 125-Anti-EGFR-425 Monoclonal Antibody | |||
| Nilutamide | |||
| Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 | |||
| Levetiracetam | |||
| Mevociclib | |||
| Gimeracil | |||
| Leuprolide Acetate | |||
| Vactosertib | |||
| Sotigalimab | |||
| Pinometostat | |||
| Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F | |||
| PKC-beta Inhibitor MS-553 | |||
| Fluzoparib | |||
| PPAR Alpha Antagonist TPST-1120 | |||
| Vector-peptide Conjugated Paclitaxel | |||
| Lutetium Lu 177 PP-F11N | |||
| Minretumomab | |||
| Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E | |||
| JAK1 Inhibitor AZD4205 | |||
| Thioredoxin-1 Inhibitor PX-12 | |||
| Ralimetinib Mesylate | |||
| Monoclonal Antibody F19 | |||
| Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711 | |||
| Peginterferon Alfa-2a | |||
| ERK1/2 Inhibitor JSI-1187 | |||
| Amsacrine | |||
| Menin-MLL Interaction Inhibitor SNDX-5613 | |||
| Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601 | |||
| Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257 | |||
| Tenifatecan | |||
| Tretinoin Liposome | |||
| Cold Contaminant-free Iobenguane I-131 | |||
| Anti-CD25 Monoclonal Antibody RO7296682 | |||
| Anti-PSMA/CD28 Bispecific Antibody REGN5678 | |||
| Vatalanib | |||
| Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C | |||
| Deslorelin | |||
| Anti-RANKL Monoclonal Antibody JMT103 | |||
| BCMA x CD3 T-cell Engaging Antibody CC-93269 | |||
| Anti-PSMA Monoclonal Antibody-MMAE Conjugate | |||
| EGFR/EGFRvIII Inhibitor WSD0922-FU | |||
| Liposome-encapsulated Daunorubicin-Cytarabine | |||
| Asparaginase | |||
| Topoisomerase I Inhibitor Genz-644282 | |||
| Imifoplatin | |||
| Vosilasarm | |||
| Opaganib | |||
| Xisomab 3G3 | |||
| Beta-Thioguanine Deoxyriboside | |||
| Mycobacterium tuberculosis Arabinomannan Z-100 | |||
| Anti-HER2 Antibody-drug Conjugate RC48 | |||
| Anti-EGFR TAP Antibody-drug Conjugate IMGN289 | |||
| Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999 | |||
| Smoothened Antagonist LEQ506 | |||
| Allogeneic Cellular Vaccine 1650-G | |||
| Protein Tyrosine Kinase 2 Inhibitor IN10018 | |||
| Cell Cycle Checkpoint/DNA Repair Antagonist IC83 | |||
| Folate Receptor-Targeted Vinca Alkaloid EC0489 | |||
| Abexinostat Tosylate | |||
| GBM Antigens and Alloantigens Immunotherapeutic Vaccine | |||
| Zotatifin | |||
| Brequinar Sodium | |||
| Eftilagimod Alpha | |||
| Endothelin B Receptor Blocker ENB 003 | |||
| Vincristine | |||
| SERD D-0502 | |||
| Etarotene | |||
| Sunitinib | |||
| Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323 |